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A note to the readers 
 
Since my studies in Electrical Engineering, I have always been interested in 
technologies with which people interact to augment their abilities and to improve 
their quality of life. During my professional experience in the development of 
assistive technologies for disabled persons, I observed many patients with 
Amyotrophic Lateral Sclerosis (ALS) who sought for technologies that could help 
them to communicate. From my early interest in ALS, I produced a master thesis 
on input devices for severely disabled patients with ALS. However, I realized that, 
despite recent advances in assistive communication devices, many patients still do 
not use these devices. I believe that there are various reasons for this, but two are 
the most critical: the lack of specific assessment tools to implement the timely use 
of assistive devices; and the absence of well-defined clinical outcomes to 
determine the benefit of these technologies for the support of ALS patients and 
their families. My main motivation to proceed in this research area is to obtain 
novel scientific knowledge that could provide relevant advances in the two critical 
problems mentioned above, in particular to test the impact of assistive devices for 
communication in the quality of life of ALS patients, and to explore the use of 
these devices as tools to mark the disease progression that would be valuable for 
home-based clinical assessment.  
This dissertation was developed under the Doctoral Program in 
Neurosciences, from the Faculty of Medicine, Universidade de Lisboa. Research 
was designed and developed in a common effort of researchers with Engineering 
and Medicine backgrounds. Assistive communication devices that were necessary 
for this research were funded by Fundação Calouste Gulbenkian and supported by 
the Associação Portuguesa de Esclerose Lateral Amiotrófica (APELA). 
 
 
This thesis is structured in eight chapters. In the first chapter, a brief 
description of Amyotrophic Lateral Sclerosis is presented, with special emphasis 
on description of functional impairments that influence communication. Chapter 2 
contains important concepts and definitions related to the field of Assistive 
Technologies. Moreover, this chapter describes the state-of-the-art of assistive 
technologies that support communication in ALS, during different stages of 
progression. Chapter 3 describes the objectives of the overall research presented 
in this thesis. Chapters 4, 5 and 6 describe the three studies performed in this 
research work, published in peer-reviewed scientific journals. Pertinent results of 
this research work are discussed in chapter 7, followed by a personal perspective 
on the presented contributions and future work, in chapter 8. After the References 
list, there are four appendices: appendix A, supports description of the study on 
speech monitoring; appendix B contains all the questionnaires used in the 
research; appendix C illustrates the use of ACD by some of the patients who 
participated in the research studies. Appendix D presents the facsimile of the 
published papers. 
Complementing this organization and presented in the initial pages of this 
thesis, there are the acknowledgments, list of figures, list of tables, list of 
abbreviations and a summary of this thesis, both in Portuguese and English. 
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A Esclerose Lateral Amiotrófica (ELA) é uma doença neurodegenerativa, 
sem cura e de causa desconhecida. É a mais frequente entre as doenças do 
neurónio motor, causando progressiva fraqueza e atrofia muscular nas regiões 
bulbar, torácica, abdominal e membros. Sem terapias que travem o implacável 
processo neurodegenerativo, a insuficiência respiratória é a principal causa de 
morte. A média de idade da ocorrência dos primeiros sintomas é de 58 a 63 anos, 
com sobrevida de 2 a 5 anos e maior incidência para o sexo masculino (1:1,4). 
Apenas 5 a 10% de doentes sobrevive por mais de 10 anos.  
As características de progressão da ELA podem variar, tendo um início 
focal com posterior difusão para outras regiões. Os doentes com ELA podem ser 
classificados pelos primeiros sintomas da doença: medular (afetando a função 
motora dos membros superiores e/ou inferiores), bulbar (afetando precocemente 
a fala e deglutição), respiratória (quando os primeiros sintomas caracterizam-se 
por dispneia), axial (afetando inicialmente os músculos do pescoço ou dorso) ou 
difusa (quando é difícil localizar os primeiros sintomas). Embora durante muito 
tempo se tenha considerado a ELA como uma doença que afetava apenas o 
sistema motor, há atualmente evidência de ser uma situação multissistémica. 
Estudos recentes indicam que cerca de metade dos doentes apresentam algum 
défice cognitivo quando avaliados por meios complementares; um reduzido grupo 
(2 a 15%) apresenta sinais clínicos de demência frontotemporal. 
Devido à crescente incapacidade motora, o doente perde autonomia para 
as suas atividades da vida diária. A maioria dos doentes experimenta graves 
dificuldades de comunicação, com consequências para a sua qualidade de vida. 
Devido ao envolvimento da região bulbar, que causa rápido agravamento da 
disartria, estudos indicam que cerca de 90% dos doentes com ELA sofre de 
dificuldade em comunicar através da fala (caracterizada por perda de 
inteligibilidade). Por outro lado, a progressiva tetraparésia causada pelo 
envolvimento medular impossibilita a escrita. O doente com ELA vê-se então num 
crescente isolamento (do qual é consciente) com graves dificuldades (ou mesmo 
impossibilidade) em comunicar as suas necessidades, sentimentos ou decisões. 
 
A falta de comunicação agrava a dependência entre o doente e cuidador, além de 
aumentar neste a frustração de não poder entender as necessidades do seu 
doente, com pressupostas consequências para a qualidade de vida de ambos.  
As dificuldades de comunicação dos doentes de ELA tornam imperativo o 
suporte das Tecnologias de Apoio à Comunicação (TaC), à medida que estes 
perdem a fala e a escrita. Desde os sintetizadores de fala (para transformar 
qualquer texto escrito em fala), atualmente presentes em qualquer smartphone, 
aos avançados sistemas de controlo pelo olhar ou as interfaces cérebro-
computador, as TaC possibilitam ao doente com ELA comunicar no seu contexto 
social, nomeadamente com o cuidador, familiares ou amigos e profissionais de 
saúde, independentemente da sua incapacidade motora e características da 
progressão da doença.  
Contudo, pelas suas características neurodegenerativas e rapidez de 
progressão, a ELA constitui um desafio a quem se dedica à investigação,  
desenvolvimento e aplicação de TaC: as características físicas do doente e as 
suas necessidades de comunicação alteram-se com o avanço da doença. A perda 
progressiva, mas não simultânea, da fala e da mobilidade nos membros 
superiores e inferiores faz com que seja necessária uma contínua avaliação das 
capacidades funcionais e das necessidades de comunicação do doente, para que 
a escolha e utilização de TaC seja adequada a cada fase da doença.  
Apesar dos enormes avanços nas TaC, durante a última década, persistem 
várias dificuldades em apoiar a sua utilização por doentes com ELA. Algumas das 
razões para estas dificuldades são: falta de evidência científica do benefício da 
utilização destas tecnologias para a qualidade de vida dos doentes e cuidadores; 
falta de ferramentas de avaliação, que permitam apoiar os profissionais de saúde 
na escolha atempada das tecnologias que melhor se ajustam às necessidades de 
comunicação e ao contexto de cada doente; e o apoio tardio, muitas vezes 
sugerido ou procurado apenas quando o cuidador já tem muita dificuldade em 
comunicar com o doente. Com frequência, em algumas fases da ELA, o doente e 
o cuidador têm de gerir complicações clínicas relacionadas com o suporte vital 
(nomeadamente, a disfagia e a insuficiência respiratória) que se tornam 
prioritárias e fazem com que o problema da comunicação seja negligenciado. No 
entanto, as graves limitações físicas do doente (logo, a elevada dependência das 
decisões do cuidador), bem como a crescente depressão ou sobrecarga do 
 
cuidador, tornam a adaptação às TaC muito difícil, quando adiada para fases 
avançadas da doença. Também relacionado com as dificuldades de apoio dos 
doentes para utilizar TaC, é discutido neste trabalho a perspetiva limitada que é 
colocada nestas tecnologias. As modernas TaC não devem ser consideradas 
apenas como alternativas à fala, mas como um importante meio tecnológico que 
potencia a integração dos doentes com ELA nos modernos paradigmas da Saúde. 
 
A presente tese tem como principal objetivo estudar o impacto que a 
utilização de TaC tem na qualidade de vida dos doentes e seus cuidadores, desde 
as primeiras dificuldades em comunicar através da fala. Como objetivos 
secundários, pretende-se (1) estudar novas ferramentas de avaliação e medição 
da capacidade de comunicação nos doentes com ELA, que possam contribuir 
para um melhor acompanhamento dos doentes ao longo das diferentes fases da 
doença; (2) validar a hipótese de que as TaC podem ser instrumentos para 
implementar ferramentas clínicas de telemonitorização, desde a casa do doente.   
Um grupo de 30 doentes com ELA e 17 cuidadores, de início bulbar, foi 
selecionado na consulta de ELA do Hospital de Santa Maria. Os doentes e 
cuidadores foram avaliados longitudinalmente, na consulta de Neurologia do 
hospital,  durante 2 a 29 meses. Em cada sessão de avaliação, os instrumentos 
utilizados para o estudo da qualidade de vida foram: para os doentes, o 
questionário McGill Quality of Life questionnaire (MQoL); para os cuidadores, o 
MQoL e o World Health Organization quality of life-BREF (WHOQoL-bref). Para a 
avaliação do desempenho na comunicação foi usada a métrica de número de 
palavras por minuto, e registaram-se as funções da fala e escrita (manual e num 
teclado). Para o estudo de novas ferramentas de monitorização, foi gravada fala 
dos doentes (utilizando o microfone de um computador) e os movimentos de 
escrita num teclado (através de um acelerómetro colocado na parte posterior do 
dedo indicador).  
Um grupo de 15 doentes (selecionados aleatoriamente) recebeu TaC 
baseadas em computadores tipo tablet, desde as primeiras dificuldades em 
comunicar.  Verificou-se que estes doentes aprenderam facilmente a utilizar as 
tecnologias, e melhoraram o desempenho de utilização da escrita com teclado. 
Observamos neste grupo de doentes um impacto positivo das TaC em alguns 
 
domínios específicos da qualidade de vida dos doentes (Psicológico e Bem-Estar) 
e seus cuidadores (Psicológico e Suporte). 
Estudamos a função do membros superiores, no que se refere ao 
desempenho na comunicação escrita. Observamos que as TaC podem suportar a 
comunicação dos doentes com ELA durante mais tempo do que a escrita manual, 
muitas vezes utilizada como única alternativa à fala (ficando o doente 
impossibilitado de comunicar quando perde a função motora necessária para 
agarrar a caneta).  
Com base na metodologia definida para registo da fala e da escrita no 
teclado, observamos em dois estudos exploratórios que as TaC podem ser 
utilizadas como ferramentas para monitorizar a progressão dos sintomas da ELA, 
nomeadamente os que dizem respeito à comunicação. Num primeiro estudo com 
19 doentes de ELA, observamos que o tempo médio que o doente demora a 
pressionar cada tecla do teclado pode ser utilizado como marcador precoce de 
disfunção nos membros superiores. Também verificamos que a aceleração dos 
movimentos ao premir e libertar as teclas indicam aumento da disfunção dos 
membros superiores na ELA. Num segundo estudo, baseado na análise 
longitudinal de fala gravada de quatro doentes de ELA, observamos a 
possibilidade de utilizar fala corrente para avaliação e detecção precoce da 
progressão da ELA. As metodologias utilizadas neste trabalho de investigação 
para o registo e avaliação da comunicação podem ser replicadas em ambiente 
doméstico, e fazem parte das contribuições desta investigação. A implementação 
de ferramentas de telemonitorização suportadas nas TaC, é discutida nesta tese.  
Com o objetivo de explorar novas ferramentas de avaliação e novos canais 
de comunicação em doentes que recebem apoio tardio na utilização de TaC, 
desenvolvemos uma ferramenta de deteção e controlo de movimentos residuais, 
simples de controlar. Foram testados movimentos captados por sensores de 
acelerometria, eletromiografia e força (que podem ser utilizados pelo doente para 
acesso a ferramentas de comunicação), em três doentes de ELA com grave 
incapacidade motora.  
Em conclusão, os resultados deste trabalho de investigação contribuem 
com ferramentas de Engenharia para a melhoria da comunicação e do 
acompanhamento dos doentes com ELA e seus cuidadores na utilização de TaC. 
As metodologias desenvolvidas para o desenvolvimento deste estudo podem ser 
 
aplicadas para estudar o impacto das TaC em outras doenças 
neurodegenerativas que afetam o controlo motor da fala e membros superiores.  
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Amyotrophic Lateral Sclerosis (ALS) is a progressive neuromuscular 
disease with rapid and generalized degeneration of motor neurons. Patients with 
ALS experiment a relentless decline in functions that affect performance of most 
activities of daily living (ADL), such as speaking, eating, walking or writing. For this 
reason, dependence on caregivers grows as the disease progresses. 
Management of the respiratory system is one of the main concerns of medical 
support, since respiratory failure is the most common cause of death in ALS. 
Due to increasing muscle weakness, most patients experience dramatic 
decrease of speech intelligibility and difficulties in using upper limbs (UL) for 
writing. There is growing evidence that mild cognitive impairment is common in 
ALS, but most patients are self-conscious of their difficulties in communicating 
and, in very severe stages, locked-in syndrome can occur. When no other 
resources than speech and writing are used to assist communication, patients are 
deprived of expressing needs or feelings, making decisions and keeping social 
relationships. Further, caregivers feel increased dependence due to difficulties in 
communication with others and get frustrated about difficulties in understanding 
partners’ needs. Support for communication is then very important to improve 
quality of life of both patients and caregivers; however, this has been poorly 
investigated in ALS. 
Assistive communication devices (ACD) can support patients by providing a 
diversity of tools for communication, as they progressively lose speech. ALS, in 
common with other degenerative conditions, introduces an additional challenge for 
the field of ACD: as the disease progresses, technologies must adapt to different 
conditions of the user. In early stages, patients may need speech synthesis in a 
mobile device, if dysarthria is one of the initial symptoms, or keyboard 
modifications, as weakness in UL increases. When upper limbs’ dysfunction is 
high, different input technologies may be adapted to capture voluntary control (for 
example, eye-tracking devices). 
Despite the enormous advances in the field of Assistive Technologies, in 
the last decade, difficulties in clinical support for the use of assistive 
communication devices (ACD) persist. Among the main reasons for these 
 
difficulties are lack of assessment tools to evaluate communication needs and 
determine proper input devices and to indicate changes over disease progression, 
and absence of clinical evidence that ACD has relevant impact on the quality of life 
of affected patients.  For this set of reasons, support with communication tools is 
delayed to stages where patients are severely disabled. Often in these stages, 
patients face additional clinical complications and increased dependence on their 
caregivers’ decisions, which increase the difficulty in adaptation to new 
communication tools.  
This thesis addresses the role of assistive technologies in the quality of life 
of early-affected patients with ALS. Also, it includes the study of assessment tools 
that can improve longitudinal evaluation of communication needs of patients with 
ALS.  
We longitudinally evaluated a group of 30 patients with bulbar-onset ALS 
and 17 caregivers, during 2 to 29 months. Patients were assessed during their 
regular clinical appointments, in the Hospital de Santa Maria-Centro Hospitalar 
Lisboa_Norte. Evaluation of patients was based on validated instruments for 
assessing the Quality of Life (QoL) of patients and caregivers, and on 
methodologies for recording communication and measuring its performance 
(including speech, handwriting and typing).  
We tested the impact of early support with ACD on the QoL of patients with 
ALS, using a randomized, prospective, longitudinal design. Patients were able to 
learn and improve their skills to use communication tools based on electronic 
assistive devices. We found a positive impact of ACD in psychological and well-
being domains of quality of life in patients, as well as in the support and 
psychological domains in caregivers.   
We also studied performance of communication (words per minute) using 
UL. Performance in handwriting may decline faster than performance in typing, 
supporting the idea that the use of touchscreen-based ACD supports 
communication for longer than handwriting. From longitudinal recordings of 
speech and typing activity we could observe that ACD can support tools to detect 
early markers of bulbar and UL dysfunction in ALS.  
Methodologies that were used in this research for recording and assessing 
function in communication can be replicated in the home environment and form 
 
part of the original contributions of this research. Implementation of remote 
monitoring tools in daily use of ACD, based on these methodologies, is discussed.  
Considering those patients who receive late support for the use of ACD, 
lack of time or daily support to learn how to control complex input devices may 
hinder its use. We developed a novel device to explore the detection and control of 
various residual movements, based on sensors of accelerometry, 
electromyography and force, as input signals for communication. The aim of this 
input device was to develop a tool to explore new communication channels in 
patients with generalized muscle weakness. 
This research contributed with novel tools from the Engineering field to the 
study of assistive communication in patients with ALS. Methodologies that were 
developed in this work can be further applied to the study of the impact of ACD in 
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Chapter 1  - Amyotrophic Lateral 
Sclerosis  
1.1 Introduction 
Amyotrophic Lateral Sclerosis is in the group of the motor neuron disorders. 
It was considered as a muscular condition until the French neurobiologist and 
physician Jean-Martin Charcot published, in 1869, a number of clinico-pathological 
studies identifying neuromotor degeneration as cause of muscle wasting (Goetz, 
2000). For his fundamental contributions, ALS is still known as “Charcot’s 
disease”.  
This motor neuron disease is distinguished by the combination of 
degeneration of upper and lower motor neurons (Figure 1). Upper motor neurons 
(UMN) are in the motor cortex and project down to connect to lower motor neurons 
(LMN). LMN reside in brainstem and spinal cord; they project to the peripheral 
nerves to connect directly to the muscle fibers. Spasticity is a well-known 
manifestation related to UMN involvement in ALS, while muscle weakness, muscle 
wasting and fasciculations are related to LMN degeneration that occurs in this 
disease. 
Symptoms are progressive weakness and wasting of bulbar, limb, thoracic 
and abdominal muscles. Most patients experiment a dramatic and progressive 
loss of muscle function. Motor neurons controlling the eye movements and 
sphincters are commonly spared, as also the sensory and autonomic nervous 
system. For a definitive diagnostic of ALS it is important to identify the presence of 
concomitant signs of UMN and LMN degeneration in multiple body regions (Shaw 
& Quinn, 2006; Brooks et al., 2000).  
ALS is rapidly progressive and fatal, with no available treatment to interrupt 
the motoneurone death; its cause is still unknown. The mean age of onset is 58-63 
years old in sporadic cases of ALS. Lifetime risk of developing ALS is 1 in 350–
500, for male sex (Miller et al., 2013); the incidence is higher for male sex (1:1,4) 
(Miller et al., 2013; Logroscino et al., 2010). Only 5% of cases have an onset 
before the age of 30 years (Haverkamp et al., 1995), but young-onset sporadic 
cases are increasingly recognized (Gouveia & de Carvalho, 2007). Due to fast 
progression, death occurs in average 2-4 years after the first symptoms, due to 
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respiratory failure, but 5-10% may survive for a decade or more (Andersen et al., 
2012; Miller et al., 2013).  
The management of ALS is supportive, palliative and multidisciplinary 
(Wijesekera & Leigh, 2009). Riluzole is the only approved drug that has been 
shown to have a modest effect in prolonging life (Bensimon et al., 2002; 
Bellingham, 2011).  
Respiratory failure and other respiratory complications account for the 
majority of deaths in ALS. Although respiratory function is a frequent late 
complication, it may be a presenting feature (de Carvalho et al., 1996). Several 
different factors have been shown to predict survival in ALS. The most consistent 
negative predictive factors for survival are: elderly age, low body-mass index, short 
diagnostic delay, bulbar and respiratory presentation, rapid clinical and respiratory 
decline (Pinto et al., 2009; Chiò et al., 2009).  
Non-invasive ventilation (NIV) is widely used to improve alveolar 
hypoventilation in ALS. Several studies indicate a longer survival when NIV is 
used. Health-related QoL is improved in patients under NIV, in particular in those 
with none to moderate bulbar dysfunction (Pinto et al., 2010; Bourke et al., 2006; 
Vrijsen et al., 2013).  Forced vital capacity, vital capacity, nasal inspiratory 
pressure obtained during a sniff, the size of the phrenic nerve motor response and 
mean nocturnal oxygen saturation have been considered as respiratory markers 
related to prognosis in ALS (S. Pinto & Carvalho, 2014; S. Pinto et al., 2009). 
Most ALS cases (approximately two thirds of patients with typical ALS) 
have a spinal form of the disease: symptoms may start either distally or proximally 
in the upper or lower limbs. Nearly 25% of the patients have bulbar-onset ALS: 
dysarthria as initial symptoms. In this group of patients, limbs symptoms can 
develop almost simultaneously with bulbar manifestations or, for most of the 
cases, will occur later within 1–2 years. All patients with bulbar symptoms will 
develop dysphagia and sialorrhea due to difficulty in swallowing saliva, as well as 
mild UMN type bilateral facial weakness, which affects the lower part of the face. 
'Pseudobulbar' symptoms such as emotional lability are seen in a significant 
number of cases (Wijesekera & Leigh, 2009). About 5% of cases with ALS present 
with respiratory weakness without significant limb or bulbar symptoms (de 
Carvalho et al., 1996). These patients present with symptoms of respiratory failure 
or nocturnal hypoventilation (dyspnea, orthopnea, disturbed sleep, morning 
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headaches, excessive day time somnolence, anorexia, decreased concentration 
and irritability or mood changes) (Polkey et al., 1999; Wijesekera & Leigh, 2009). 
Bulbar-onset is more common in women and in older age groups; 43% of 
patients over the age of 70 present bulbar symptoms, compared to 15% below the 
age of 30 (Forbes et al., 2004; Haverkamp et al., 1995). In general, death is due to 
respiratory failure within 2–3 years for bulbar onset cases and 3–5 years for spinal 
onset ALS cases. Most ALS cases are sporadic but 5–10% of cases are familial, 
and of these 10-20% have a mutation of the SOD1 gene and about 20-40% have 
mutations of the C9Orf72 gene, in Europe (Wijesekera & Leigh, 2009; Cooper-
Knock et al., 2015).  
The deterioration of the neuromotor system involved in respiration, 
phonation, swallowing, and lingual and oro-facial muscle functions leads to a 
rapidly progressing dysarthria in ALS. Dysarthria occurs in more than 80% of 
patients and is manifested as an early symptom in patients with bulbar-onset, 
often leading to anarthria. It also affects 70% of patients with spinal onset; 25 to 
30% of patients have dysarthria within initial symptoms (Tomik & Guiloff, 2010). 
Dysphagia is a common symptom of ALS, leading to malnutrition, weight 
loss, dehydration and the need of aspiration (Kühnlein et al., 2008). Percutaneous 
endoscopic gastrostomy is the standard procedure for alternative feeding; 
evidence suggests that it should be placed before vital capacity falls below 50% of 
predicted (Wijesekera & Leigh, 2009).  
ALS is characterized by functional decline related to muscle weakness, 
affecting most activities of daily living (Cedarbaum et al., 1999). Dependence on 
caregivers grows as disease progresses (Brownlee & Bruening, 2012). Increasing 
dependence and general dysfunction of patients with ALS cause strong negative 
social and economic impact. Patients and caregivers may suffer from depression 
and anxiety, from diagnosis and as disease progresses. Psychological support 
and palliative care should be offered to the families since early symptoms (Averill 
et al., 2007). Most patients will experiment dramatic decrease of speech 
intelligibility and great difficulties in writing due to increasing muscle weakness. For 
this reason, one of the concerns of persons with ALS is the fear of losing ability to 





Figure 1 – Pathways of Upper Motor Neuron and Lower Motor Neuron systems (in (Shaw et al., 
2006), p.2) 
1.2 Functional progression 
ALS may be identified by the functional involvement of one or more central 
nervous system region (bulbar, cervical-upper limbs, lumbosacral-lower limbs or 
thoracic-diaphragmatic) evaluated by manifestations of weakness, wasting or 
spasticity. First symptoms spread to other contiguous anatomic regions, in a 
progressive order. Time of progression can vary according to survival rates, and 
be influenced by clinical, demographic, and genetic features (Simon et al., 2014).  
Brownlee & Bruening (2012) describe ALS as a disease of losses. In fact, a 
dramatic decrease in patients’ autonomy is caused by a cascade of functional 
losses. ALS Functional Rating Scale revised (ALSFRS-R) (Cedarbaum et al., 
1999) is a widely applied tool for research and routine clinical evaluation, that 
measures in a single score the severity of the functional status. The ALSFRS-R 
measures bulbar function, gross motor tasks, fine motor tasks, walking, and 
respiratory function. Maximum score (48) corresponds to normal function; this 
score declines as disease progresses (minimum is 0). Quality of life is correlated 
to ALSFRS-R scores, indicating that function is important in the QoL of ALS 
patients and their caregivers (Bourke et al., 2006; Cedarbaum et al., 1999). This 
score has been used as a self-report form (Montes et al., 2006), for telephone 
administration (Kaufmann et al., 2007; Kasarskis et al., 2005) and online 
assessment (Maier et al., 2012). For these characteristics, this tool was used for 
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clinical functional assessment in this research, and is further described in section 
4.2.4. 
A staging system proposed by Roche et al. (2012), characterizes ALS 
progression in four stages: (1) Symptom onset (involvement of one single region); 
(2) Involvement of a second region; (3) Involvement of a third region and (4) A- 
Need for gastrostomy, B- Need for respiratory support (non-invasive ventilation). 
Quantitative outcome measures of functional progression in ALS, used in clinical 
trials, mainly rely on muscle strength assessment, respiratory and bulbar function 
tests as well as on general functional rating scales (Brinkmann et al., 1997). 
Emerging imaging technologies are contributing to further insights of the disease, 
in particular related to the study of UMN abnormalities in ALS (Simon et al., 2014).  
1.3 Upper and Lower limbs dysfunction 
Symptoms of ALS include difficulties of movements and reduced strength in 
upper and lower limbs. Due to lower limbs dysfunction, patients may fall and 
progressively become unable to walk. Loss of physical independence related to 
upper limbs dysfunction is characterized by progressive difficulties in performing 
most activities in daily living, as handwriting, handling utensils and dressing 
(Cedarbaum et al., 1999). 
Figure 2 depicts a simplified model for dysfunction, considering a simplified 
linear progression: walking with autonomy, moving on a wheelchair and, finally, 
living mainly at home. For the scope of assistive communication devices in ALS, 
this simplified model represents three stages where significant changes in 
communication needs and individual social contexts can occur.   
 
 
Figure 2 – A suggested model of the progression of limbs dysfunction, considering a simplified and linear 
progression of ALS. Three stages where significant changes in communication needs and individual social 
contexts can occur are represented: (i) the patient can walk normally (with independence for most ADL), (ii) 
the patient moves on a wheelchair and has difficulties in moving upper limbs (becomes more dependent on 
the caregiver and loses autonomy for several ADL) and (iii) finally, the patient is severely impaired and 
dependent on the caregiver (lives mainly at home, on a chair or bed).  
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1.4 Speech dysfunction 
Different types of dysarthria occur in ALS, according to systems that are 
affected. Frequently it has mixed characteristics due to multisystemic involvement. 
Degeneration of LMN results in flaccid bulbar palsy with denervation of muscles of 
face, oropharynx, larynx and tongue (muscle wasting and weakness with 
proportional slowness of movements). Involvement of cortical areas and 
corticobulbar tracts (UMN) causes spastic bulbar palsy (slowness of movement 
with variable weakness and no wasting) (Darley et al., 1969). Figure 3 resumes 
dysarthria characteristics in ALS disease, as suggested in (Tomik & Guiloff, 2010).  
 
 
Figure 3 – Type, mechanisms and clinical signs of Dysarthria in ALS (from Tomik & Guiloff, 2010) 
 
Decline of functional speech is characterized by decrease in speech 
intelligibility. Patients experiment progressive difficulties in being understood by 
others, increasing need to repeat words, reduction of the group of listeners who 
understand their speech, until they are unable to use speech for communication. 
In a longitudinal analysis, Beukelman et al. (2007) observed that 80 to 95% of ALS 
patients were prevented from communicating without any alternative strategy, in 
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some stage during disease progression. Ball et al. (2004) studied 158 patients, in 
3 months intervals, since diagnosis until death concluding that speech rate is a 
valid predictor for decrease of speech intelligibility. According to Ball et al. (2007), 
a speech rate of 125 words per minute (65% of normal speech rate) is a valid 
marker for rapid decline in speech intelligibility. 
1.5 Cognitive impairment 
It is now evident that ALS disease affects multiple systems, with a 
significant impact for cognitive deficits. High incidence of mild cognitive impairment 
(up to 50%) has been reported (Phukan et al., 2007; Lomen-Hoerth et al., 2003; 
Barson et al., 2000); frontotemporal dementia (FTD) is found in a reduced group of 
ALS patients (with prevalence ranging from 15 to 41%) (Strong et al., 2009). 
Although cognitive impairment manifestations are heterogeneous, its decline has 
been described by personality change, irritability, obsessions, poor insight and 
pervasive deficits on frontal executive functions (i.e. verbal fluency, mental 
flexibility, attention, working memory, planning, and abstract reasoning) (Phukan et 
al., 2007; Cipresso et al., 2012). Different longitudinal studies indicate that 
cognitive decline is slow in the absence of dementia (Phukan et al., 2007; 
Robinson et al., 2006), but progresses more rapidly in bulbar-onset patients, when 
compared to spinal-onset (Schreiber et al., 2005). Motor and speech impairments 
raise difficulties for studying neuropsychological aspects of the disease. In stages 
where patients have lower functional scores, assessment with neuropsychology 
tests need modifications that accommodate physical impairment and the possibility 
to use ACD to answer to digital modified neuropsychology test. However, 
heterogeneity of physical impairment and difficulty in collecting large samples are 
obstacles to validation of these test modifications (Hill-Briggs et al., 2007). Some 
authors suggested the use of Brain-computer interface (BCI) or eye-tracking 
systems to assess cognition by neuropsychological tests in patients with severe 
motor impairment. Nevertheless, the lack of research in test modifications adapted 
to different devices reduces the possibility of studying cognition in later stages of 




Chapter 2  - Assistive Technologies for 
Communication and Control in ALS 
2.1 Definition of Assistive Technology 
The term Assistive Technologies is defined by Cook & Polgar (2013) as a 
broad range of devices, services, strategies and practices that are conceived and 
applied to ameliorate the problems faced by individuals who have disabilities. In 
the same perspective, Cowan & Turner-Smith (1999) define Assistive 
Technologies as “any device or system that allows an individual to perform a task 
that they would otherwise be unable to do, or increases the ease and safety with 
which the task can be performed”.  
According to Rehabilitation Engineering Society of North America (RESNA), 
the term AT Device (ATd) means “any item, piece of equipment, or product 
system, whether acquired commercially, modified, or customized, that is used to 
increase, maintain, or improve functional capabilities of individuals with 
disabilities”.  This definition is adopted from Assistive Technology Act of 2004, P.L. 
108-364 (http://www.gpo.gov/fdsys/pkg/STATUTE-118/pdf/STATUTE-118-
Pg1707.pdf). The same document defines AT Service as “any service that directly 
assists an individual with a disability in the selection, acquisition, or use of an 
assistive technology device”. AT services include evaluation of individuals’ needs 
(which includes functional evaluation), support in acquisition of ATd, customization 
and technical support for ATd, coordination between the use of ATd and 
rehabilitation services; training users, professionals and caregivers; among others.  
2.2 Assistive Communication Devices (ACD) 
Different ATd are developed to assist different functional disabilities. 
Assistance in communication, mobility, cognition, manipulation, vision, audition 
and tact are the targets of the ATd (Cook & Polgar, 2013). For example, a 
wheelchair is developed and used to improve patients’ mobility; an infrared 
transmitter that is controlled by eye-tracking system can allow a severely motor 
disabled patient to choose TV channels from the bed; an application in a 
smartphone that alerts for daily tasks can help a person with memory problems; 
screen readers in the computers help individuals with vision impairment to access 
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to information; auditory prosthesis allow individuals with auditory impairments to 
improve listening performance; an electromyographic interface can allow a 
severely disabled individual with motor speech impairment to write on a screen 
keyboard and use text-to-speech to communicate with others. All these examples 
refer to ATd that are developed to assist in different functional needs.  
The present work is devoted to AT for support in communication. In this 
scope, the term ATd will be replaced by assistive communication devices (ACD). 
We refer to ACD as any device or system that enables an individual to 
communicate when they would otherwise be unable (or have difficulties) to do it, 
due to functional impairments. A unique reference to the field of Augmentative and 
Alternative Communication (AAC) is done in this paragraph. According to ASHA, 
“Augmentative and alternative communication includes all forms of communication 
(other than oral speech) that are used to express thoughts, needs, wants, and 
ideas.” In fact, all the present research work is in the scope of the field of AAC. 
However, a special focus is given on the technology (electronic devices) and 
effects of the use of ACD. 
In this context, ACD aim at enhancing communication of those patients who 
have difficulties in speaking or writing. In ALS, as also in several other neurological 
conditions, difficulties in communication appear due to physical dysfunction in 
speech and in upper limbs. Depending on physical dysfunction and individual 
needs, different technologies can support communication, as tablet devices or 
computers with software-based communication tools (e.g. speech synthesis), 
simple devices that record and reproduce voice, eye glasses with embedded gaze 
control or even intracortical brain computer interfaces.   
It is important to note that, in opposition to most clinical equipment, which is 
controlled by the professionals, ACD are to be used by patients. This fact makes 
them distinct from other technologies for clinical support and has important 
implications: 
i) expertise in the use of ACD belong to the patient. 
ii) outcomes from the use of ACD are difficult to obtain in clinical settings, 
as these technologies are designed to enhance patients’ function in daily living, 
out of the clinical environment. 
iii) use and selection of ACD must follow a patient-centered approach 
(Stewart, 2001), taking into account the individual context and decisions of each 
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patient. As Gosnell et al. (2011) advocate, while ACD must “represent a 
reasonable match to the strengths and needs of some individuals, it is important 
that the needs of an individual be considered on a case-by-case basis using a 
thorough and clinically based approach.”   
2.2.1 Input devices 
As aforementioned, ACD are operated by the patient. Operation is done 
using an input device (most commonly named as access interface), i.e. a mean of 
interaction between the body functions (input signals) and the ACD. Most 
commonly, interaction between a person and a personal electronic device is done 
through motor control of upper limbs. For example, touchscreens or keyboards are 
input devices that are used by the patient (requiring motor control of upper limbs) 
to access to an ACD (Figure 4).  
 
 
Figure 4 – Input devices (accessibility tools) are controlled by body functions and translated into 
commands for controlling communication tools of the AT device. 
 
Input devices have particular importance in ALS in the context of patients 
with upper limbs impairment. In a neurodegenerative process of losing motor 
control, as is the case of ALS, use of upper limbs to control a device may become 
limited or impossible. As disease advances and functional limitations increase, 
patients’ support in Communication includes searching for alternative resources 
(body functions and input devices) to access to ACD. Miyasaka et al. (2013, 
p.165) illustrate an example where they observe the finger joint movements 
required to perform a left click on a computer mouse input device and problems 
that arise as ALS progresses: 
“To click the left mouse button, the hand rests on the mouse while maintaining a 
longitudinal and lateral arch in the palm and the four fingers and thumb envelop and grip the 
mouse. Then, with the distal interphalangeal and proximal interphalangeal joints of the left-side 
finger slightly flexed, the angle of each joint is maintained and the metacarpophalangeal (MP) joint 
is flexed to perform the clicking operation. After clicking, the flexion of the MP joint is relaxed to 
cease the clicking operation. Clicking the left mouse button thus involves the complex operation of 
simultaneously holding the mouse and clicking the button, which requires the coordination of 
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several joint muscles. Because muscle strength throughout the body deteriorates as ALS 
progresses, input methods, such as the mouse, requires the use of multiple muscles and therefore 
become unusable after the early stages of the disease.” 
As these same authors refer, as disease progresses, input devices that 
minimize the number of joint movements are selected. Figure 5 illustrates body 
sites and input signals that are most commonly used by ALS patients for access to 
ACD, depending on disease symptoms and stage.  
 
 
Figure 5 - Body sites and signals commonly used to control input devices by ALS patients. 
 
2.2.2 Access Methods 
Depending on the input signals (Figure 4) and the body functions that are 
used to access to ACD, two main access methods may be used: 
(i) Direct selection – in this access method, patient can choose a function 
in the ACD directly. For example, when using a keyboard with finger selection or 
an eyetracking system with eye control, the patient can select any letter at any 
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instance. Motor control allows the user to reach any option in the keyboard 
directly. 
(ii) Scanning method – when physical disability prevents the patient to 
access to all functions in ACD, an alternative method must be used. For example, 
a patient with ALS may not be able to move upper limb to reach all keys in a 
keyboard, thus be able to press a switch using hands or head movements, as 
depicted in Figure 6. A single switch (a simple 0/I signal) may be used to select a 
device with a scanning method: all options in an onscreen keyboard are 
highlighted in a sequential order and defined frequency (e.g. 1 option/sec). When 
the desired option is highlighted, user will press the switch and select that option 
(Figure 6). Scanning process continues for further selections. Despite of being a 
slow process 
 
Figure 6 - (left) Switch being used by a patient with ALS for accessing to communication tools in an 
ACD using a scanning method. (right) Scheme illustrating scanning method (in Encarnação et al. (2015), 
p.61). 
 
of selection, scanning method is used by many ALS patients, with the support of 
acceleration techniques (e.g. text prediction or different scanning sequences). It is 
important to refer that, in particular for patients in late stages of ALS, easiness for 
setup and learning of the input device may be more important for the patients than 
the communication rate. Birbmauer (2006) describes difficulties to find volunteers 
for implanting intracortical brain computer interfaces: “Even when informed about 
the possibilities and advantages of the surgical implantation, 16 patients refused 
the procedure and preferred the slow and error-prone noninvasive device. An 
important argument of patients was that time is not an issue if one is completely 
paralyzed”. In fact, acceptance of assistive technologies is dependent on other 
factors than velocity, as is discussed in chapter 4. 
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There is also another specific scanning method that is used on some brain 
computer interfaces. In this specific case, which further described in section 
2.3.2.3, scanning is not sequentially driven. Instead, options are highlighted in a 
random order and patients have to look at their option until it highlights.  
2.3 Assistive communication and dynamic needs in ALS 
When assessing to communication needs in ALS, and generally in 
progressive neurological conditions, three important aspects should be 
considered: 
(i) Communication support must include assessment of input devices and 
ACD (access and communication tools). In ALS, both speech and upper limb 
functions are severely affected. As so, patients will need communication tools (for 
example, a speech synthesizer) and specific access tools to compensate 
functional impairment in upper limbs (for example, an input device to access a 
keyboard using eye movements) (Fager et al., 2012).  
(ii) Time and characteristics of symptoms and progression deeply influence 
communication and access needs. Some characteristics that are specific of ALS 
are determinant for the specification of ACD that should best match to patients’ 
communication and control needs. It is then especially important to estimate the 
rate of progression and know the stages of the disease, to plan ACD according to 
expected advance of the symptoms.  
(iii) Communication needs depend on each patient’s individual needs and 
context and may not be restricted to replacing speech dysfunction. Communication 
needs of the patients may go beyond dysfunction of speech. Solving 
communication problems in today’s digital world requires consideration of multiple 
functions, depending on the age, circumstances, interests, and preferences of 
each person. Interpersonal communication, information, online services, 
entertainment, education, health and safety, are different functions of present 
communication tools, services and facilities (Shane et al., 2012).   
In the following sections, we describe the state-of-art of assistive 
technologies that are used for supporting communication in ALS. Firstly, we 
describe technologies that are used in initial phases of disease progression 
(depending if main disability is in bulbar or upper limbs), and then those 
technologies that are used when patients are severely affected.  
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2.3.1 ACD in moderately affected patients 
2.3.1.1 Initial speech impairment 
When patients experiment speech intelligibility decay, though keeping 
functional upper limbs, the most inexpensive communication aids are pen and 
notepad (handwriting) or printed boards, as depicted in Figure 7. Though, 
generation of tablet devices is having a tremendous impact on the possibilities of 
communication for these patients (McNaughton et al., 2013; RERC, 2011). Simple 
and inexpensive applications can allow a patient to communicate with others, for 
example by using a simple touchscreen-activated keyboard and voice output 
(based on text-to-speech technologies). The possibility of using Internet 
applications as communication tools included in any tablet device is also an 
opportunity for patients to avoid social isolation caused by decreased speech 
intelligibility (Shane et al., 2012).  
Handwriting and pointing to printed alphabetic boards are communication 
tools that are limited to peer-to-peer communication and can be used until 
functional impairment in upper limbs does not definitely prevent its use (Figure 7 
and Figure 8). Digital ACD, such as the tablet devices, have the advantage of 
allowing the patient to use the same communication tools, as new input devices 
can be connected to these devices, to adapt to functional changes imposed by 
disease progression. Moreover, patients may be able to write using direct 
selection on a keyboard for more time than handwriting (as described in Chapters 
4 and 5). Several authors defend the use of handwriting or printed boards in 
parallel to digital ACD, for being practical instruments, easy to use in any context 
(Brownlee & Bruening, 2012; Bongioanni, 2008; Kühnlein et al., 2008; Miyasaka et 
al., 2013).   
2.3.1.2 Initial upper limbs impairment 
When muscle weakness first affects UL function, patients may experiment 
early difficulties in using writing (handwriting or typing in an electronic device) or 
grabbing/controlling devices (for example, difficulties in using a cell phone). These 
difficulties may occur before any perceived symptom of dysarthria. One of the 
main overwhelming problems of losing UL function is loss of autonomy in daily 
living and consequent restricted participation in social and leisure activities (Sveen 
et al., 1999; Bongioanni, 2008). 
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Figure 7 - Alphabetic Board printed in paper; the user points to the desired letters, words, phrases or 
pictures to communicate. This alphabetic board can also be used when patients are severely disabled: the 
caregiver points to the letters and patient indicates the selection by eyeblink or other gesture. In Encarnação 
et al. (2015), p.89.  
 
 
      
Figure 8 – (Left) Example of handwriting as a replacement of speech function. (Right) This note was 
written by a patient with ALS (bulbar onset) participating in this study; due to low intelligibility of speech, this 
woman wrote about her symptoms to communicate with her neurologist. 
 
As muscle weakness increases, the use of alternative input devices for 
accessing communication tools becomes progressively important, as depicted in 
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Figure 9. Lack of understanding of UL functional progression in ALS, in what refers 
to access to ACD, limits support in early stages (Londral et al., 2013). Instead, 
access tools that do not rely on UL movements have been extensively explored in 
ACD research. In section 2.3.2, we describe input technologies that have been 
developed for ALS patients with severe UL dysfunction. 
 
   
Figure 9 – One of the participants in this research: (left) she could type on the keyboard using both hands; 
(right) six months later, the same patient could not perform more than slight movements with left hand fingers 
(with the hand closed). 
 
Wicks et al. (2009) proposed an extension for ALSFRS-R, in which there is 
a new item related to ULs and the use of assistive devices: 
Compared to the time before you had symptoms of ALS, has your ability to use your 
fingers been affected when using the keys of a computer, speech device, remote 
control, or environmental controls? 
4: no change; able to type or press buttons quickly with any finger 
3: can press buttons or type but at a reduced rate  
2: can only press some buttons or type very slowly  
1: can only activate one key or switch at a time 
0: Am unable to activate any key or switch with fingers 
 
When accessing to keyboards or switches, some difficulties may be 
observed:  
(i) Increasing difficulties in pressing or releasing a button or key. When this 
happens, it is important to allow patients to press the key or switch for a longer 
period, by eliminating the function of repetition (often, pressing for a longer time 
will activate the command to repeat the command; this option should be turned-





Figure 10 - Repetition of letters in a typing task of an ALS-patient participating in this research. Repetition is 
caused by abnormal delay in releasing the finger from the key 
 
(ii) Patients may have difficulties in raising and moving the arm to point and 
select items on a keyboard or an alphabet board. Some patients may use arm 
supports to augment distal function of upper limbs (Londral et al., 2009): if forearm 
is supported higher that the keyboard, the hand will drop over the keyboard and 
patient will be able to select and press the keys (Figure 11).   
 
            
Figure 11 – (left) A patient who participated in our study is using the left hand to support his right 
forearm and enhance upper limb function in typing; (right) Representation of the distal function of UL when 
forearm is supported. 
 
2.3.1.3 Voice banking  
At this early stage, when bulbar symptoms are not perceived, ALS patients 
have the opportunity to anticipate speech dysarthria. Voice banking is an 
increasing practice for communication support in ALS. Patients record 
speech/voice for later incorporation in assistive communication device. Recorded 
voice allows personal and more authentic expression, when comparing to the 
inexpressive voice of speech synthesizers (Costello & Dimery, 2014).  Guidelines 
for voice banking of patients with ALS are available online (for example in 
http://www.alsforums.com/guides/documents/Voice-Banking-Guidelines.pdf).  
A very promising technology for ALS patients is the personalized speech 
synthesis. Voice features are extracted from the user and combined with a 
surrogate voice, generating a synthesizer with vocal identity of the user (Mills et 
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al., 2014; Yamagishi et al., 2012; ACAPELA, 2014). Despite voice banking should 
be done while ALS patient has no perceived speech disorder, there are techniques 
in which disordered speech can be repaired after recorded to be used in 
personalized synthesis; voice banking from familiar voices was also proposed to 
be used as a complement of patient’s voice (Yamagishi et al., 2012).   
2.3.2 Input signals and ACD in severely disabled patients 
2.3.2.1 Eye movements 
Advances in eye tracking technologies were responsible for the outbreak of 
eye-gaze input devices occurred in last two decades, also denominated by 
eyecontrol. Generalization of these devices brought new communication tools for 
those with severe upper limbs impairment, in particular ALS patients with 
decreased upper extremity motor function.  
Many different methods have been developed to detect and track eye 
movements. The first methods were developed more than 100 years ago for 
research of reading. Initial methods for tracking the location of eye fixations 
involved direct mechanical contact with the cornea (Javel, 1878). Non-invasive 
techniques development to track eye movements started in the first half of 20th 
century. The first attempt was based on the use of light reflected from the cornea 
and recorded onto a photographic plate; further techniques based on combination 
of cornea reflection and motion picture techniques were developed by several 
scientists interested in studying eyes movements. Jacob and Karn (2003) describe 
in detail the history of eye-tracking systems, since the pioneer study with cornea 
reflection (Dodge & Cline, 1901) until precise and accurate systems of our days. 
The discovery that multiple reflections from the eye could be used to dissociate 
eye rotations from head movement (Cornsweet & Crane, 1973) improved tracking 
precision and also prepared the ground for further developments that today allow 
greater freedom of movements from users. 
Most of the commercially available eye-gaze input devices are based on 
optical methods to measure eye motion, particularly one called “corneal-
reflection/pupil-center” (Poole & Ball, 2005). This method is based on an infrared 
light that is generated by a LED in a camera (usually this camera is below the 
computer screen). Infrared is used for being invisible to humans eye. It is directed 
to the eyes, to create a strong reflection. Two images are captured by the camera 
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of the eye tracking system: the pupil is captured as a large bright dot and the 
cornea reflection (the first Purkinje image1) is detected as a small glint (as 
depicted in Figure 12). Vector formed from the center of the pupil and the corneal 
reflection gives accurate information on the eye position (point-of-regard). 
Techniques using multiple reflections from the eye, firstly proposed by Cornsweet 
and Crane (1973), increase accuracy by allowing to dissociate eye rotations from 
head or camera movements (Kolakowski & Pelz, 2006). 
 
    
Figure 12 - Most common method for detecting eye movements for computer control in ACD are 
based on two images: the pupil and cornea reflection.  
 
Using eyes as an input device (i.e. eyecontrol) for an ACD has some 
inherent difficulties. As Jacob & Karn (2003) describe in detail, the eye moves very 
differently from the intentional way the hand moves to perform a voluntary 
movement.  Idea of using eye movements to choose options on a screen (e.g. 
choosing letters in an onscreen keyboard) and performing other pointing tasks is 
not as trivial as it may seem. On one hand, eyes can be used as a high-speed 
pointing device with no need for training, since brain dominates the control of this 
input. On the other hand, eye gaze is a sensory input that is related to complex 
cognitive tasks - eyes movements are often performed non-intentionally and not 
consciously. Typically, the user looks at the target on the screen and fixes gaze for 
a specific time (dwell time). This time acts like a threshold for a selection. As this 
input device is always “turned on” (a problem denominated as Midas Touch2) it 
can be frustrating and fatiguing to use it as input device for a specific task (for 
example, writing in the computer). Some methods were implemented in these 
input devices to avoid this problem. For example, using a different input device to 
perform selection (a switch or eye blink), instead of fixing eyegaze; another option 
                                            
1  Also named Purkinje-Sanson images due to Czech anatomist Jan Evangelista Purkyně (1787–1869) and 
French physician Louis Joseph Sanson (1790–1841). 
 
2 Everywhere you look another command is activated; you cannot look anywhere without issuing a command. 
(Jacob e Karn, 2003, pp.589-590) 
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is to use a mode of “standby” that user can activate and deactivate using eye-gaze 
based commands.   
Good cognitive capabilities, few involuntary movements and absence of 
motor neuron degeneration in ocular motor nuclei related to eye muscles makes 
ALS patients one of the most important target group for eye-gaze access 
technologies. Input devices based on these technologies are small cameras that 
are placed on the screen of the computer, to track eye movements and translate 
them as a pointer to select any item in the screen. Recent advances in eye 
tracking devices integrated in augmented reality glasses are promising wearable 
communication tools for ALS-patients who are severely disabled.  
Nevertheless, there are some drawbacks. Despite that muscles related to 
eye movements are usually spared in ALS, there can be problems with reliability in 
using eye-gaze access in late stages of ALS. Sellers et al. (2010, p.3) report the 
case of a patient who had a proficient use of the ACD: “However, as his eye 
movements weakened, the device became unreliable, and he and his family 
despaired of his being able to continue the independent communication essential 
to his quality of life and to his professional productivity”. Problems in system 
calibration or the need to repeat it often, difficulties due to inexperience in the use 
of a keyboard, previous vision problems, too many head or body movements or 
the need to have an ideal positioning (body and camera positions) were reported 
in other studies as difficulties in using this technology with ALS patients (Ball et al., 
2010; Calvo et al., 2008). For its technological complexity, eye tracking systems 
may need more support for troubleshooting than other systems, which is a 
drawback for those patients living in long-term care facilities, where support for AT 
is scarce (as discussed in Chapter 6 ).  
 
Technologies to detect eye movements that are based on non-optical 
methods are less used in the context of ALS patients. Electro-oculogram (EOG) is 
one of these non-optical technologies. It is based on detecting electrical muscle 
signals from the eye movements, as depicted in Figure 13. This technique has 
been developed by many researchers and proposed as input device for those with 
no upper limbs movements. As advantages, EOG signals have relatively high 
amplitude (when comparing to EEG), relationship between EOG and eye 
movements is linear, and eye movements are simple to detect (Lv et al., 2008). 
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Advantages that are related to the use of biosignals are further discussed in 
Chapter 6 . The EOG is the electrical signal obtained from potential difference 
between a positive pole, the cornea, and a negative pole, the retina (where there 
is a large number of nerve cells) and the cornea. Signal from this ocular dipole can 
thus be estimated by measuring the voltage induced across a system of 
electrodes placed around the eyes.  
 
 
Figure 13 – Picture of an input device based on EOG capture (in Fricke et al. (2014), p. 196). 
 
As the eye gaze changes, EOG can vary from 50 to 3500 µV, with a 
frequency range of about 100 Hz DC. It varies practically linearly for gaze angles 
of ±30º (Barea et al., 2002; Siriwadee et al., 2012). The amplitude of pulse will be 
increased with the increment of the rolling angle. EOG signals have certain 
patterns for each kind of eye gaze movement (horizontal movements: left, right; 
vertical movements: up, down; blink or wink) (Uşaklı, 2012). Several authors 
suggest EOG techniques for communication of ALS patients with severe motor 
impairment (Tsai & Chen, 2009; Dhillon et al., 2009; Park et al., 2005; Murakami et 
al., 2012). Using classification of different patterns in the EOG signal 
(corresponding to different eye movements), various methods are suggested, as 
writing on an onscreen keyboard by moving a cursor in two directions or blinking 
for switch input. Uşaklı (2012) developed an EOG system to ALS patients, 
reporting better accuracy, speed, applicability, and cost efficiency, when 
comparing their EOG system with a P300-based BCI system. In spite that EOG 
has been suggested as accurate input devices and potentially useful for patients 
with ALS or other severe motor disorder, results reported from experimental 
research were performed in healthy persons. 
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Miyasaka et al. (2013) refer to systems using this technique as having the 
advantage of detecting eye movements regardless the positioning of the patient or 
the opening angle of eyelids. Nevertheless, main problems of this technique are: 
the setup, as depicted in Figure 13, is not practical to implement in real scenarios 
of ALS and it is dependent on movements’ speed to detect an input signal. 
Furthermore, occulomotor dysfunction, as slower saccades, vertical gaze palsy or 
abnormal eyelid movements have been observed in ALS patients (Okuda et al., 
1992; Abe et al., 1995).  
2.3.2.2 Head and neck movements 
Although it is observable that slight head and neck movements are 
generally preserved until late stages, in the majority of patients, these are not 
evaluated for a functional perspective. However, Wicks et al. (2009) suggest a 
new item to add to ALSFRS-R:  
 
To what extent have there been changes in your ability to move your head?  
4 - no change; can move head in all directions from a vertical position without head support  
3 - can move head in all directions from a vertical position with head support  
2 - can move head in all directions from a reclined or tilted back position with head support, 
and can nod or tilt head  
1 - can move head from left-to-right from a reclined or tilted back position with head support 
but have a very limited range of motion 
0 - cannot move head 
 
Frequently, when patients cannot use ULs to access communication tools, 
they are still able to control head movements to activate a head mounted switch 
or, in some cases, a headmouse.  
The switch activated by head movements is often used by ALS patients 
with no UL movements (as depicted in Figure 14). Despite that this input device 
relies on scanning method (section 2.2.2), which is slower than other input devices 
(for example, comparing to eye-tracking input devices), it has the advantage of 
being simple and easy to use and to setup. Especially for those patients with lack 
of support for AT use, for example if a patient is living in a long-term care 
residence, the head mounted switch is a valid, feasible and efficient input device to 
use communication tools.   
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Figure 14 – A patient with severe dysfunction of upper limbs (ALSFRS-R-ul=0) using a head 
activated switch to control a keyboard based on the scanning method. 
 
A headMouse is an input device that tracks head movements. Most 
common systems use a camera with an infrared transmitter, placed below or 
above the computer screen. Users wear a small and discrete infrared reflector (like 
a small dot) that is placed on the forehead, glasses or hat (Figure 15). As user 
moves their head, the camera tracks head’s movements and translates them to 
pointing (mouse) control. Selections (mouse clicks) are performed either by a 
dwell time or by an external switch, as similar to eye-gaze input devices. Other 
approaches for headmouse use computer vision methods to visually track body 
features from real-time video. Eye, nose, lip, chin, thumb or dark light tracking 
were suggested by Betke et al. (2002) as body segments that can be used for 
tracking head movements to voluntary control a pointing input device.   
 
 
Figure 15 – (up) A man with ALS (who cannot move his upper limbs to control a computer mouse or 
to type) using an input device based on head movements. (down) Picture of the computer screen showing a 




Despite the high sensitivity of head tracking, the necessary range of neck 
motion and the potential fatigue may reduce performance, when comparing to eye 
tracking systems. Bates and Istance (2003) found, in an experiment with healthy 
participants, that headmouse had shorter learning times and required lower 
workload with higher comfort to low experienced users, when compared to eye 
tracking pointing devices. Though, uncertainty in time of use due to the disease 
progression is the reason for preference of eye-tracking systems for ALS patients. 
Despite the lack of studies on the effectiveness of headmouse devices in ALS, 
these input devices are mentioned in various sources in Internet related to ALS, as 
ALS Associations websites or reports of patients’ testimonials (for example in Wolf 
(2007), a patient testimonial refers: “because of its flexibility and the excellent 
support (…), the HeadMouse served me well for about three and a half years”. Ball 
et al. (2010) refer to the example of an ALS patient who progressively did 
transition from head mouse to eye tracking due to extensive fatigue when using 
head movements. 
2.3.2.3 Brain activity 
A BCI is an input device that is controlled solely by brain activity. In last two 
decades, there was a rapid growth in BCI research, motivated by the hope that 
this technology can be a new communication channel for those who are severely 
disabled and cannot rely on muscle control for communication. Brain signals are 
recorded by BCI and transmitted as a control signal to an ACD, to external 
prosthetic devices or even directly to muscles (Figure 16). 
Invasive BCIs use brain signals that are recorded from inside the body 
including: (1) action potentials from nerve cells or nerve fibers (2) synaptic and 
extracellular field potentials, and (3) electrocorticograms. Noninvasive BCIs are 
those that record brain signal with sensors placed out of the body. The brain 
signals recorded by this type of BCI are: (1) slow cortical potentials (SCP) of the 
EEG, (2) EEG and MEG oscillations, mainly sensorimotor rhythm (SMR), also 
called mu-rhythm, (3) P300 and other event-related brain potentials, (4) BOLD 
response in functional magnetic resonance imaging, or (5) near-infrared 




   Figure 16 - Brain computer interface (McFarland & Wolpaw 2011, p.62). 
 
Mainly those ALS patients who opt for artificial respiration may reach a 
state of locked-in state, with sparse (or any) voluntary muscle control. Visual P300 
and SMR are the brain signals that showed better results in ALS (Birbaumer, 
2006), but the first is the most mentioned in studies related to use of BCI by ALS 
patients. When patients have vision problems, auditory stimuli are an alternative to 
visual stimuli in P300-BCI (Nijboer et al., 2010).  
Despite the promising results of this technology and the effort in developing 
simple and reduced cost devices and other applications than spelling (Holz et al., 
2013; Schreuder et al., 2011; Bai et al., 2010; Münßinger et al., 2010; Mugler et 
al., 2010), some drawbacks persist. Training periods are long, professionals need 
to give continuous support due to its complex setup; signal-noise ratios are low; 
several electrode and skin problems occur due to long recording times; spelling 
speed is slow; choice of communication tools that can respond to individual needs 
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of BCI users is reduced; and ultimately, it demands high effort from the user, who 
must be very focused during spelling and spend many hours in training until they 
reach a reasonable success rate (Blain-Moraes et al., 2012; Sellers et al., 2010; 
Birbaumer, 2006).  
Invasive BCI are attractive because using subdural implanted electrodes, 
signal to noise ratio is higher and success rate may improve significantly. 
Nevertheless, experiments with ALS patients or other in locked-in states (LIS) 
have been scarce and not successful, in part due to lack of persons in such 
conditions who agree to go through surgical implants. Wilhelm et al. (2006) report 
that 16 in 17 ALS patients in late stages (using invasive ventilation) rejected to 
implant macroelectrodes, even after being informed on the advantages of invasive 
BCI. Those patients preferred to use a slower input device for communication than 
going through surgical implantation. Furthermore, it is still not clear the influence of 
the disease and its progressive conditions in BCIs performance, when comparing 
patients with ALS in late stages to LIS due to other neurological conditions. Slow 
and inconsistent responses from ALS patients in late stages observed in invasive 
BCI may be caused by deterioration of cognitive functions or other disease 
constraints, as episodes of anoxia (Sellers et al., 2010; Birbaumer, 2006).  
Combination of non invasive BCI with other input technologies, as eye 
tracking, headmouse or switch input devices, in multimodal or combined 
approaches have been reported as methods to reduce error rate, improve user 
performance and increase user acceptance as ALS disease progresses (Gürkök & 
Nijholt, 2012; Cincotti et al., 2008; Zander et al., 2010).  
2.3.2.4 Other input signals 
Mouth and tongue movements. Mouth-controlled text input devices (Cheng-
Hong et al., 2003; Wu et al., 2010) and tongue-operated computer input devices 
(Huo et al., 2008; Yousefi et al., 2011) were proposed to the severely impaired. In 
spite that patients with ALS are referred as eligible candidates for these 
technologies, we found no reports on experiments with these patients.  
Electromyography and other biosignals. Input devices based on 
electromyography have been proposed by several authors, for interaction with 
computer. These methods are attractive because sensors can be placed in any 
part of the body where minor muscle activity exists. Also, the effort to generate 
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voluntary EMG signal is lower than for pressing a mechanical switch. These have 
also been proposed as input signals for rapid selection (like a mouse click) in eye-
tracking pointing devices (Surakka et al., 2004; Chin et al., 2008). As main 
problems of the EMG-based input devices are the noise from involuntary muscle 
activity that may generate false commands, difficulties related to sensors fixation 
or complex setup procedures (Pinheiro et al., 2011). In ALS, muscles in upper 
limbs and face may be good candidates for EMG control, despite lack of research 
studies on electrodes position for EMG control in ALS. Nöjd et al. (2008) 
presented a study on optimal position of electrodes for facial EMG and EOG, 
although results were performed with healthy subjects. As ALS is a neuromuscular 
disease, EMG control must be assessed for each patient, since there may be no 
general conclusions on optimal body region to place the electrodes. Moreover, it is 
expected that neurodegeneration process will lead to the need to change body 
region to place the electrodes. Concerning other input biosignals, Moore & Dua 
(2003) report the development of an input device based on the Galvanic Skin 
Response. This input device was tested in one patient with ALS. Mariano et al. 
(2014) developed an input device based on accelerometry to detect residual 
movements in severely disabled patients, though experiments were undertaken 
with healthy subjects.  
2.4 Impact of cognitive impairment on the use of ACD    
Until recently, ALS patients were elected as ideal candidates for assistive 
communication because it was thought that patients had no cognitive deficits. 
Despite that cognitive functional decline has been identified in the last two 
decades, its influence in AAC acceptance is still not clearly understood.  
Some studies identify difficulties in the use of AAC possibly related to 
cognitive impairment. Ball et al. (2004) considered that primary reason for AAC 
rejection was early FTD symptoms, as observed in 2 (out of 50) participants in 
their study. Rejection was associated to spinal onset and rejection was not just in 
technological solutions but in any kind of communication support. These authors 
pointed-out resistance to change, inflexibility of thought and rigid personality trait, 
reported by Lomen-Hoerth et al. (2003) and Strong et al. (2009), as the main 
limitations for AAC acceptance. In another study, Cipresso et al. (2012) concluded 
that poor concentration, distractibility, and short-term memory difficulties, should 
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be taken into account, in order to adequately plan and realize AAC sessions to 
ALS patients for the use of P300-BCI technology. 
However, other studies report that cognitive deficits in ALS seem to have a 
negligible effect in the use of technological devices for communication. Beukelman 
et al. (2011) prospectively analyzed a database of 87 patients supported in the 
same hospital. Multidisciplinary clinical screen revealed 18.4% and 4.6% patients 
with mild cognitive impairment and FTD, respectively; 77% did not reveal cognitive 
impairment. According to the authors, just 2 patients with mild cognitive 
impairment and 2 patients with FTD were not successful in the use of AAC. The 
same authors report that, while their ALS clinical team manifested concern on 
patients’ cognition when referring to communication support, this seem to have not 
affected those patients’ acceptance and successful use of AD to meet their 
communication needs.  
 Brownlee & Bruening (2012) pointed-out to the fact that executive function 
interferes with decision-making – a resource need when selecting the AAC device 
or in the learning/training process for using the device or for deciding new access 
strategy. However, in accordance to results in the study of Beukelman et al. 
(2011), it is critical to distinguish between cognitive impairment scores resulting 
from neuropsychological standardized assessment and functional cognitive skills 
in daily living. Each individual with ALS reacts to the loss of communication in a 
unique way and may change over time, depending on many personal, physical or 
social factors. A close support to the patients in their decisions and in anticipating 









Chapter 3  - Rationale, objectives and 
methods 
3.1 Rationale 
Recent mass marketing of tablet and smartphone devices, as well as 
advances in novel input technologies (such as touchscreens, eye tracking devices 
or BCI) observed in the last decade, represent a new generation of ACD with 
enormous potential impact in support of patients with ALS and other neurological 
conditions (McNaughton et al., 2013; Fager et al., 2012b; Beukelman et al., 2011). 
These ACDs provide not just an alternative to speech, but also communication 
tools connected to a new generation of Internet services that may remotely 
support patients in health and social care (Shane et al., 2012; van den Broek et 
al., 2009). As reported by INTEL (2008), “technologies that can improve and 
enhance [patients’ and caregivers’] social connectedness will be at an advantage”. 
For example, using the internet for online assessment of ALSFRS-R, as 
suggested by Maier et al. (2012), or using the computer for supporting advanced 
care planning, as suggested by Hossler et al. (2011), are examples of the potential 
benefits of modern ACD as tools to access to clinical support. Further, as the 
benefits of home telemonitoring of non-invasive ventilation have been 
demonstrated for ALS (A. Pinto et al., 2010), ACD could potentially augment these 
benefits by allowing remote communication between health professionals and the 
patient, along the whole course of the disease.  
Despite the technological advances, several main difficulties related to the 
support for ACD in ALS persist: (1) the lack of clinical outcomes that could confirm 
the expected positive impact related to the use of these technologies; (2) the lack 
of clinical assessment tools to evaluate the progression of patients’ functional 
impairment that specifically affects the use of ACD; (3) late referral (when patients 
are severely disabled and extremely dependent on others’ decisions); and (4) a 
limited perspective on ACD, often solely considered as an alternative to speech.   
Communication is a concern in recent clinical guidelines for ALS 
management (Miller et al., 2013; Andersen et al., 2012), though lack of clinical 
evidence on the benefits of ACD for ALS patients may hinder its general use and 
funding. Two recent prospective studies indicated a positive impact of ACD in the 
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QoL of ALS patients. Körner et al. (2012) studied the impact of ACD on the mood 
and quality of life of a group of ALS patients who used ACD, compared with a 
group of patients who did not use ACD. Caligari et al. (2013) studied the impact of 
using ACD based on eyetracking interaction on the QoL of a group of ALS 
patients. However, there is limited evidence documenting how the use of ACD 
from the early stages of disease progression affects QoL of patients and their 
caregivers. 
As speech dysfunction increases, ALS patients move from speech to 
written communication (Murphy, 2004a). While speech has been extensively 
studied in ALS, in particular concerning characteristics and progression of 
dysarthria, written communication, in terms of function of UL movements, is not 
well characterized. Ball et al. (2001) indicated speech rate as a predictor of 
deterioration of speech intelligibility in ALS. However, taking into consideration that 
most of the ALS patients will have difficulties in using UL for handwriting or 
accessing to mainstream devices to write (e.g. a smartphone), further research on 
how long can a patient rely on UL movements for communicating is needed.  
Most of the studies related to the use of ACD rely on groups of patients that 
are already severely disabled. One example is the high enthusiasm from the 
research community for BCI specifically oriented for ALS patients. In fact, late 
referral is a common practice, since patients, caregivers and health professionals 
tend to postpone decisions on the use of ACD until no other alternatives are 
possible. Nevertheless, late referral has been studied as a difficulty for successful 
use of ACD by ALS patients (Beukelman et al., 2011; Brownlee & Bruening, 2012).  
Light & McNaughton (2014) refer to motivation and confidence as general 
psychosocial factors involved in the competence to using ACD. These factors may 
be affected in late stages of ALS (Nijboer et al., 2010), in particular when input 
devices are difficult to set up or need a significant time to learn. Further studies on 
the impact early support in the use of ACD are necessary to improve patients’ 
communication during the whole course of disease progression.  
3.2 Objectives 
The overall purpose of this PhD thesis is threefold: (1) to investigate the 
impact of ACD on QoL of early-affected patients with bulbar-onset ALS and on 
their caregivers; (2) to test the hypothesis that ACD can support tools for remote 
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functional monitoring; and (3) to identify novel methods to assess quantitatively the 
functional performance of patients in communication, in different stages of ALS. 
 
 Our contribution is expected to: 
 i) Reveal scientific evidence that early support with ACDs has a positive 
impact on the QoL of ALS patients and their caregivers, even in a population with 
poor experience with the use of computer devices; 
 ii) Identify novel methodologies to monitor UL function, related with the use 
of ACD.  
iii) Broaden the classical perspective of ACD as technologies with the single 
purpose of improving communication, by demonstrating its potential application as 
in-home clinical remote monitoring tool.  
 iv) Show how to explore the potential of input biosignals generated by 
residual muscular movements in the body, to enhance communication in very 
affected ALS patients.  
v) Contribute with methodologies for the development of new input devices, 
based on the concept that ACD should be changed over disease progression, 
taking into account the necessary flexible adaptation to the patient and caregivers 
conditions.  
3.3 Organization of the research 
The research work is organized in three chapters: chapter 4 - Quality of life 
in ALS patients and caregivers: impact of assistive communication; chapter 5 - 
Monitoring disease progression with assistive communication devices: speech and 
typing activity and chapter 6 - Communication during stages of severe dysfunction: 
development of a new input device to assess novel input signals. 
3.4 Methods 
Most research was based on longitudinal data collected from a 
homogeneous population of 30 early-affected bulbar-onset ALS patients followed 
at the ALS outpatient consultation of the Department of Neurosciences  (Hospital 
de Santa Maria-Centro Hospitalar Lisboa Norte), over a period of 29 months. As 
there were no previous studies including our outcomes, we could not calculate the 
number of patients required to attain the expected results. We estimated that 
recruitment of 30 patients would be appropriate to our goals.  
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Patients with bulbar-onset symptoms were selected for the following 
reasons: (a) they present early speech dysfunction; (b) this group is understudied 
(concerning the use of ACDs);  (c) they represent 25-30% of total number of ALS 
patients, in general with a faster progression rate. 
All data presented in this dissertation was collected in clinical environment, 
both by myself and by medical doctors in Neurology and Rehabilitation, co-authors 
in the main publications supporting this thesis.  
Quality of life, methodologies for assessment of communication 
performance and markers of disease progression were the main clinical outcomes 
in this research. Other outcomes related to behavioral dysfunction in the use of 
technology, assessment tools and new input devices are of interest for the 












Chapter 4  - Quality of life in ALS 
patients and caregivers: impact of 
assistive communication  
4.1 Introduction 
Recent recommendations for clinical management in ALS indicate that 
patients’ autonomy and ability to communicate should be promoted (Miller et al., 
2013; Andersen et al., 2012). Accordingly, communication has been rated by ALS 
patients as one of the most important domains for their own independence (Gruis 
et al., 2011).  
Severe dysarthria has great impact on the QoL of ALS patients, since most 
patients become unable to communicate through speech at some stage of the 
disease, in spite of speech therapy interventions (Tomik et al., 1999; Körner et al., 
2012).  
In bulbar-onset patients, early deterioration of speech intelligibility (Ball et 
al., 2001) leads to rapid replacing of speech by handwriting (often a pen and a 
notepad for peer-to-peer communication), until UL muscle weakness demands 
new strategies for communication (Brownlee & Bruening, 2012; Bloch & Clarke, 
2013). In any case, as the disease progresses, most patients must replace speech 
by communication based on text input (handwriting, use of computer or paper-
based letter board). 
Modern tablet devices used as tablet-based assistive communication 
devices, with touchscreen input, can allow bulbar-onset patients to maintain 
autonomy in communication, through simple applications with speech 
synthesizers. Nevertheless, its use is strongly dependent on the decision and 
expectations of patients, their caregivers and health professionals. As long as 
residual capacity for communicating through speech or handwriting is present, the 
use of communication devices may not be considered. When communication 
alternatives lack (severe dysarthria associated with severe UL dysfunction), 
technologically more advanced methods have to be explored. Timely referral and 
economic burden remain critical issues in decision-making for communication 
support in ALS. Besides, late referral is one of the main causes for low 
acceptance; indeed, the adaptation of patients with marked generalized weakness 
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to new strategies (e.g. eye-tracking or even brain-computer interfaces) can be a 
difficult process, especially when there is lack of experience or support for 
continuous training in the use of these ACD (Brownlee & Bruening, 2012; 
Beukelman et al., 2011).  
Particularly, when patients’ disability is severe, the use of ACD relies on the 
caregivers’ support for daily setup and maintenance. For this reason caregivers’ 
needs, skills and expectations must be considered as important factors in clinical 
intervention with ACD (Beukelman et al., 2011; Murphy, 2004b). Difficulty to 
understand patients’ needs and feelings is the chief caregivers’ motivation for 
supporting intervention with ACD (Fried-Oken et al., 2006). Furthermore, patient´s 
autonomy regarding communication has been reported as an essential family 
caregiver need that may influence their own quality of life (Williams et al., 2008).  
The main outcome of the present study is to explore, longitudinally, the 
impact of the introduction of tablet-based ACDs on the quality of life of early-stage 
bulbar-onset ALS patients and their caregivers. Secondary outcomes are self-
perceived communication and performance of writing (handwriting and typing) in 
order to monitor UL function regarding their use in ACD based on touchscreen 
input.  
4.2 Materials and Methods 
4.2.1 Patients 
ALS patients were included with the following inclusion criteria: probable or 
definite disease according to the revised El Escorial criteria (Brooks et al., 2000); 
bulbar-onset, as defined by initial symptoms of dysarthria and/or dysphagia; bulbar 
score of dysarthria of 3 or 2 (mild or moderate impairment) as given by the first 
question of the ALSFRS-R; informed consent. Patients with other medical 
conditions, respiratory symptoms or clinical evidence of dementia were excluded. 
Main caregiver was identified by the patient as the person providing daily support 
and accompanying them in the clinical visits (frequently the husband/wife or a 
sibling). The caregiver did not change over the duration of this study.  
The research was approved by joint Ethics committee Centro Hospitalar 
Lisboa Norte-Faculdade de Medicina de Lisboa and patients and caregivers gave 




Patients were assessed three times: at entry (T0); 3-4 months later (T1); 7-
10 months after entry (T2). Caregivers were assessed 2 times, at T0 and T2. 
Assessments were made at our clinic, exceptionally at the patient’s home. At each 
visit, patient and caregiver were interviewed separately. The duration of the 
complete assessment was 30 minutes, approximately. At T0 patients were also 
randomized in 2 groups according to the intervention time (Group 1, G1 - Early 
intervention, patients received a ACD just after baseline assessment; Group 2, G2 
- late intervention, patients were followed and received communication devices 
according to the conventional approach in our centre (referral when dysarthria 
score is 0 or 1 on the ALSFRS-R, meaning anarthria or severe dysarthria). ACD 
consisted in a small and light touchscreen-tablet device (approximately 
200x130mm), commercially available in the market.  We used a software based on 
a simple onscreen keyboard for text-to-speech communication with text prediction 
(Figure 17). This software was commercially developed for the specific purpose of 
text-to-speech communication and is available to download from the internet; for 
our choice, an important feature was that this software included the possibility to 
be used with different access strategies, alternative to touchscreen. Patients and 
caregivers were trained and supported, during local clinical appointments, for 
using this ACD. Those patients who had internet connection at home were 
instructed to use email communication through the ACD. Email communication 
was tested and stimulated by sending emails (demanding reply) periodically, 
during the period of this study.  
 
  
Figure 17 – A participant of this study using an assistive communication device: writing on a 
touchscreen-accessed keyboard with speech synthesis. 
Patients underwent the following questionnaires: McGill Quality of Life 
questionnaire (MQoL), ALSFRS-R and modified Communication Effectiveness 
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Index (CETI-m). Caregivers completed the questionnaires MQoL and World Health 
Organization quality of life-BREF (WHOQoL-bref), related to their own QoL. All 
these tests have been used in ALS, as well as they have been translated and 
validated in Portuguese. 
Both patients and caregivers answered to a self-designed questionnaire, 
rated on a 0 to 5 Likert-type scale, to assess to previous experience with computer 
devices (Table 1).   
4.2.3 Quality of Life  
4.2.3.1 McGill Quality of Life questionnaire 
The MQoL (Cohen et al., 1995) consists in a questionnaire with 16 items, 
each rated on a Likert-type scale from 0 to 10. Questions include two health-
related domains (Physical symptoms and MQoL-Phys: Physical well-being), three 
non-health related domains (MQoL-Psych: Psychological symptoms, MQoL-Exist: 
Existential well-being and MQoL-Support: Support (related to the feeling of being 
cared), a single-index score (MQoL-SIS) and a descriptive section (MQoL-part D), 
where the inquired can list what had greatest impact (positive or negative) on their 
QoL in the past two days. This instrument has a total score (MQoL-tot) and 
subscores for each domain, range 1 to 10 (higher scores indicate greater QoL). It 
is sensitive to psychological, supportive and spiritual factors, more than to health 
related QoL measures (Epton et al., 2009). MQoL has been used in various 
studies related to QoL of ALS patients (Gauthier et al., 2007; Chiò et al., 2004; 
Robbins et al., 2001). 
4.2.3.2 World Health Organization quality of life-BREF (WHOQOL-BREF) 
WHOQOL-BREF (Skevington et al., 2004; WHOQOL Group, 1998) is a 26-
item questionnaire for measuring QoL in four domains: (1) physical health and 
well-being; (2) psychological health and well-being; (3) social relations; (4) 
environment (related to financial resources, health and social services, home and 
physical environment, among others). Items are rated on a 1 to 5 Likert-type scale 
and scores are calculated for a 100 points scale (greater scores correspond to 
better QoL). Ratings range from 1 (very poor) to 5 (very good). This questionnaire 
has been extensively used to investigate QoL of patients and caregivers in 
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different chronic diseases, including ALS (Baumann et al., 2012; Lo Coco et al., 
2005). 
4.2.4 Functional Measurements  
ALSFRS-R was applied at each visit. It is an instrument used for monitoring 
progression of functional disability of patients with ALS (Cedarbaum et al., 1999). 
Each question in ALSFRS-R (total of 12 questions) is rated from 4 (normal 
function) to 0, according to progressive functional impairment. We registered the 
total score (ALSFRS-R), which is rated from 48 (normal) to 0, and two subscores: 
bulbar function (ALSFRS-R-b) (Pinto et al., 2009)  and upper limb function 
(ALSFRS-R-ul) (Kollewe et al., 2011). Subscores are rated from 12 to 0 and were 
calculated by summing the first three questions and the fourth to sixth questions of 
ALSFRS-R, respectively. ALSFRS-R-b rates speech, salivation and swallowing 
functions; ALSFRS-R-ul rates UL function related to handwriting, handling utensils 
in daily activities and dressing.  
The modified Communication Effectiveness Index (CETI-m) (L. Ball et al., 
2004b) is an adaptation from the original CETI designed for persons with aphasia. 
It is a valid measure of functional communication and is sensitive to changes in 
performance over time (Lomas et al., 1989). The CETI-m rates self-perceived 
limitation of a person when communicating; it consists of 10 questions related to 
communication in different contextual situations rated on a visual Likert-type scale. 
Total score is given by the sum of the individual scores, presented on a 100-point 
scale, representing the minimum (0) to maximum (100) communication 
effectiveness.   
4.2.5 Performance measures  
To monitor performance of UL in written communication, at each evaluation 
session, patients were asked to write, sequentially, three different sentences with 
two different modalities: handwriting and using a keyboard (Figure 18). Both 
performance of handwriting and typing on a keyboard were calculated as the 
mean rate of the writing tasks, measured as words per minute (wpm).  
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Figure 18 - Assessment of performance in handwriting (left); assessment of performance in typing 
(right).  
4.2.6 Statistical Analysis 
Primary outcomes were scores from MQoL (single index item, total score, 
physical, psychological health, existential well-being and support) and WHOQoL 
scores (four domains: physical health and well-being; psychological health and 
well-being; social relations and environment). Secondary outcomes were 
ALSFRS-R total, ALSFRS-R-b, ALSFRS-R-ul, CETI-m, typing rate and 
handwriting rate. 
Descriptive statistics was used to characterize participants and results of 
the self-designed questionnaire. Pearson and Spearman correlation coefficients 
were used to examine associations among different variables, for normal and non-
normal data distribution, respectively. Changes in outcome variables, between T0 
to T2, were analyzed by paired sample T-test and Wilcoxon Signed Rank test. T-
Test and Mann Whitney U for independent samples were used to test differences 
between the two different groups (G1 vs G2). A p-value of <0.05 was considered 
for statistical significance. For each of the statistical analysis, we used Bonferroni 
adjustment of the p value for multiple comparisons. However, taking into account 
the exploratory profile of this study, we considered p<0.05 without correction for 
multiple comparisons as a trend that was worth reporting. 
4.3 Results 
Twenty-seven ALS patients with a mean age of 64.8 (SD=10.2; range: 39 to 
83) were included. From these, one declined immediately after baseline 
assessment and 5 were evaluated only twice due to rapid disease progression 
(Figure 19).  Only 17 caregivers were interviewed (4 patients came to clinical visits 
alone or with different persons; 6 caregivers declined to fill-in the questionnaires). 
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Most of patients were women (81.5%), the previous experience in the use of 
computers, rated by patients from 0 to 5, was, generally, low (median: 2). Low 
school education and poor previous experience with technology of most of the 
participants is in agreement with the demographic characteristics of the 
Portuguese population within this age group. Table 2 describes demographic data 
of participants.  
 
 
Figure 19 - Flowchart of the recruitment process. N, number of patients; Nc, number of caregivers.  
 
Patients in G1 started to use the ACD after baseline assessment (Figure 
17). There was no record of spontaneous use of assistive communication devices 
in patients randomized to G2. Table 3 presents mean scores of the outcome 
variables of this study, for each time of assessment.  
We analysed each domain of QoL questionnaires and compared scores 
between different assessments and groups of patients and caregivers. No 
significant result was found when considering the adjusted p-value for multiple 
comparisons (Table 3 and Table 4). However, we observed a trend in favor of the 





Table 1. Questionnaires and tests applied and respective ranges. 
Test/questionnaire Range Time 
ALSFRS-R 0 (max disability) to 48 (normal) T0,T1,T2 
ALSFRS-R-b  0 (max disability) to 12 (no bulbar symptoms) T0,T1,T2 
ALSFRS-R-ul  0 (max disability) to 12 (no upper limitations) T0,T1,T2 
WHOQoL-BREF 0 (poorest QoL) to 100 (max QoL) T0,T2 
MQoL 
MQoL-sis (single item score) 
0 (lowest QoL) to 10 (highest QoL) 
0 (very bad) to 10 (excellent) 
T0,T1,T2 
Communication Effectiveness Index 
(CETI-m) 
0 (no communication) to 100 (normal) T0,T1,T2 
Performance in typing 
Performance in handwriting  
words per minute (wpm)  T0,T1,T2 
Self designed questionnaire for patients 
and caregivers: 
How much are you familiar to computer 
devices? 
 
0 (I never used a computer) to  




4.3.1 Quality of Life  
4.3.1.1 Patients  
Mean values calculated for all patients (through MQoL) showed a decrease 
in total, physical and existential domains of quality of life (p<0.05), as described in 
Table 3. Single-index score, psychological symptoms and support domains did not 
change with time (p>0.05). In descriptive parts of MQoL (physical symptoms and 
part D), twenty three patients (88.5%) referred, in one or more assessments, to 
speech problems or difficulty to be understood by others, as negative factors in 
QoL; two patients in G1 referred to communication device as having a positive 
impact in QoL. 
 
Table 2. Characteristics of all participants at baseline (T0): patients and caregivers. 
 Patients Caregivers 
Total (N) 
Gender (f/m) 
Mean age (standard deviation)(range) 
Education 
- Primary school 
- Elementary/High school 
- University  
Relation of caregiver 
- Husband/wife 
- Sibling 
Previous computer experience  
(Level 0 to 5) median(mode) 































Table 4 shows comparison between scores obtained for patients in G1 and 
those in G2, in the three periods of evaluation. Patients with early intervention with 
ACD had higher MQoL scores than the other patients, in particular for existential 
well-being domain at T1 (p=0.045), and psychological symptoms domain, both at 
T1 (p=0.047) and T2 (p=0.032) – when considering p-values without correction for 
multiple comparisons.  
Table 3. Mean values of dependent variables tested in this study, for the whole population of patients 
considering the time of assessment (T0, T1, T2) as the independent variable.  Statistical significance was 
calculated for adjusted p-value for multiple comparisons (Bonferroni method). However, p-values <0.05 
without correction for multiple comparisons were accepted as a trend.   
  T0   T1   T2     
  Mean SD MEAN SD MEAN SD p (T0,T2) 
ALSFRS-R  27.18 8.54 22.15 8.96 15.50 7.88 <0.001*
† ‡  
ALSFRS-R-b 6.32 2.71 4.75 2.47 2.75 2.05 <0.001*‡ 
ALSFRS-R-ul 9.45 3.04 8.25 4 6.44 4.34 0.002*
 † ‡ 
Handwriting rate 16.2 6.6 14.1 9.8 10.7 9.8 0.002* 
‡ 
Typing rate 9.2 5.2 8.5 5.4 6.7 4.9 0.317 
CETI-m 67.17 28.6 45.50 23.65 39.53 20.9 <0.001 
‡ 
MQoL-tot (patient) 6.64 1.18 6.32 1.12 5.75 0.95 0.010 
‡ 
MQoL-SIS (patient) 6.04 1.69 5.64 1.75 5.10 1.84 0.054
 † 
MQoL-Phys (patient) 5.50 2.10 4.92 1.82 4.42 1.5 0.027 
‡ 
MQoL-Psych (patient) 5.06 1.96 4.91 2.02 4.35 1.57 0.141 
MQoL-Exist (patient) 7.15 1.76 7.03 1.41 6.12 1.62 0.025 
‡ 
MQoL-Sup (patient) 8.46 1.78 8.52 1.91 8.63 1.05 0.710
 † 
MQoL-tot (caregiver) 5.64 1.48 NA NA 5.21 1.56 0.177 
MQoL-SIS (caregiver) 5.13 1.51 NA NA 3.73 2.12 0.030 
‡ 
MQoL-Phy (caregiver) 5.5 2.37 NA NA 5.21 2.36 0.675 
MQoL-Psych (caregiver) 4.76 2.12 NA NA 4.15 2.24 0.398 
MQoL-Exist (caregiver) 6.42 1.03 NA NA 6.16 1.67 0.624 
MQoL-Sup (caregiver) 5.92 1.81 NA NA 5.42 2.23 0.428 
WHO-phys (caregiver) 65.85 15.92 NA NA 49.74 19.59 0.009* 
‡ 
WHO-psych (caregiver) 63.28 18.89 NA NA 54.72 18.89 0.038 
‡ 
WHO-social (caregiver) 60.42 23.86 NA NA 60.12 17.04 0.749 
WHO-envir (caregiver) 63.09 10.35 NA NA 48.75 13.3 0.003* 
‡ 
 
* indicates statistical significance for adjusted p-value (Bonferroni method), paired-t test 
† indicates statistical significance for adjusted p-value (Bonferroni method), calculated for comparison 
between T0 and T2, by Wilcoxon Signed Rank Test;  
‡ indicates p<0.05, without correction for multiple comparisons (trend) 
NA = not applicable 
 
4.3.1.2 Caregivers 
Mean scores of caregivers’ quality of life (MQoL) (Table 3) decreased from 
T0 to T2, though just the single-index score (MQoL-SIS) attained a difference with 
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p<0.05. Mean scores of WHOQoL-bref showed a decrease (p<0.05) in all 
domains, from T0 to T2, except for Social Relations domain (p=0.749). In 
descriptive item of MQoL (part D), eight (47%) caregivers referred to patient´s 
speech problems as having a negative impact in their own quality of life; 5 out of 
11 (46%) caregivers of patients in G1 considered ACD as having a positive impact 
in their quality of life. 
 
Table 4. Mean values of dependent variables tested in the three evaluation periods (t0, t1, t2), comparing 
results between G1 and G2. There were no statistical significant differences between the two groups, 
considering adjusted p-value for multiple comparisons (Bonferroni method). Statistical comparisons with p-
value less than 0.05 are indicated in the table as significant. 
 T0     T1     T2     
 G1  G2  p G1  G2  p G1  G2  p 
 MEAN SD MEAN SD  MEAN SD MEAN SD  MEAN SD MEAN SD  
ALSFRS-T 25.86 9.30 29.50 6.99 0.207
† 21.23 7.81 23.86 11.26 0.201 15.17 7.00 16.50 11.36 0.136 
ALSFRS-B 5.57 2.24 7.63 3.11 0.070 4.31 2.04 6.14 2.73 0.088 3.00 2.22 3.83 3.06 0.516 
ALSFRS-R-ul 9.21 3.47 9.88 2.23 0.192
† 8.15 3.48 8.43 5.13 0.715 † 6.25 4.22 7.00 5.29 0.776 
Handwriting rate 16.67 6.86 13.4 2.96 0.326 14.28 9.53 8.51 8.06 0.831 11.8 9.97 10 8.96 0.778 
Typing rate 9.05 5.50 9.46 5.10 0.716† 8.34 4.68 8.80 7.10 0.337 7.99 5.02 7.09 6.53 0.761 
CETI-m 64.67 27.26 71.33 31.92 0.592 44.53 20.63 47.11 29.31 0.570 48.83 16.24 17.20 11.80 0.027‡ 
MQoL-tot  
(patient) 6.82 1.10 6.37 1.42 0.382 6.69 1.04 5.76 1.17 0.063 5.97 0.93 5.07 0.97 0.205 
MQoL-SIS  
(patient) 5.73 1.62 6.44 1.81 0.329
† 6.00 1.84 5.00 1.73 0.255 5.00 1.81 5.40 2.70 0.792 
MQoL-Phys 
(patient) 5.45 2.16 5.53 2.13 0.927 5.00 1.92 4.82 1.78 0.811 4.50 1.51 3.80 1.30 0.774 
MQoL-Psych 
(patient) 5.34 2.21 4.68 1.57 0.405 5.61 2.20 4.01 1.39 0.047‡ 4.93 1.59 3.18 1.10 0.032‡ 
MQoL-Exist 
(patient) 7.25 1.60 7.00 2.03 0.728 7.52 1.37 6.40 1.24 0.045‡ 6.53 1.65 5.02 1.15 0.155 
MQoL-Sup (patient) 8.77 1.62 8.05 1.98 0.318 8.79 1.67 8.18 2.21 0.456
† 8.54 1.10 8.80 1.15 0.639 
MQoL-tot 
(caregiver) 5.39 1.38 5.97 1.37 0.423 NA NA NA NA NA 5.10 1.57 5.37 1.68 0.766 
MQoL-SIS 
(caregiver) 5.00 1.48 5.33 1.37 0.650
† NA NA NA NA NA 3.56 2.13 4.00 2.28 0.706 
MQoL-Phy 
(caregiver) 4.73 2.24 6.67 2.25 0.109 NA NA NA NA NA 4.00 1.93 6.83 1.94 0.019‡ 
MQoL-Psych 
(caregiver) 5.05 2.41 3.65 1.38 0.212 NA NA NA NA NA 4.23 2.09 4.05 2.62 0.892 
MQoL-Exist 
(caregiver) 6.05 0.84 6.80 1.17 0.148 NA NA NA NA NA 6.23 1.71 6.07 1.77 0.869 
MQoL-Sup 
(caregiver) 6.30 1.44 4.42 1.83 0.633 NA NA NA NA NA 6.71 1.41 3.92 2.13 0.016‡ 
WHO-phys 
(caregiver) 68.57 17.56 61.31 12.86 0.396 NA NA NA NA NA 44.44 16.76 59.28 22.53 0.184 
WHO-psych 
(caregiver) 62.08 19.09 65.28 20.18 0.756 NA NA NA NA NA 50.46 17.73 61.11 20.36 0.392 
WHO-social 
(caregiver) 60.00 26.87 61.11 20.18 0.932 NA NA NA NA NA 58.33 15.02 63.33 21.73 0.530
† 
WHO-envir 
(caregiver) 63.13 10.91 63.02 10.35 0.662
† NA NA NA NA NA 48.27 8.72 49.48 19.31 0.870 
† corrected p-value < 0.05,  by Mann-Whitney U Test and by t-test for independent samples 
‡ indicates p<0.05, without correction for multiple comparisons (trend) 




Comparing results from caregivers of patients in G1 vs G2, no statistically 
significant difference was found for the corrected p-values. However, considering 
the uncorrected p-value < 0.05 as a trend, we identified a higher quality of life in 
G1, for the following domains: physical well-being (p=0.019) and support 
(p=0.016) (Table 4). No differences between the two groups (p>0.05) were found 
in any of the WHOQoL-bref domains (Table 4).  
Caregivers’ MQoL scores and patients’ MQoL scores were not correlated in 
any of the periods (p>0.05). 
4.3.2 Functional Measurements 
As expected, evaluation of bulbar function (ALSFRS-R-b score) decreased 
significantly over time (Table 3); decline was linear as showed no difference in the 
percentage of change between T0-T1 and T1-T2. We found no significant 
difference between the two groups of patients, regarding bulbar score decline 
(Table 4). The higher the bulbar impairment (lower ALSFRS-R-b scores), the lower 
the self-perceived communication effectiveness index (CETI-m) of patients in G1 
(r=0.419, p<0.001) and G2 (r=0.809, p<0.001). However, when considering data 
from patients in G1, after they started to use ACD (T1 and T2), patients with lower 
bulbar functional scores did not necessarily have lower self-perceived 
communication (r=0.101, p=0.629).  
In general, we found positive correlations between patients’ quality of life, 
bulbar function and self-perceived communication: the higher the bulbar 
dysfunction (lower ALSFRS-b score), the lower the quality of life, both in total 
score (r=0.297, p=0.019) and in single-item score (r=0.280, p=0.028). Patients 
with higher scores in self-perceived communication effectiveness had higher 
quality of life, both in total score (r=0.268, p=0.027) and in psychological 
symptoms domain (r=0.265, p=0.029).     
No correlations were found between caregivers’ QoL scores and patients’ 
bulbar function (ALSFRS-R-b) or communication (CETI-m) scores, for the whole 
group of caregivers. However, when analyzing caregivers of patients who received 
early ACD intervention, we found that patients with higher self-perceived 
communication had caregivers with higher scores in quality of life, for 
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4.3.3 Performance measures 
Performance of handwriting had a mean of 17.5 wpm (SD=8.1; range: 7.6 
to 36.4), at T0, and it decreased significantly (p=0.002) from baseline assessment 
to T2 (mean=12.4; SD=10; range: 0 to 27.4) (Table 3). The lower the UL function 
(ALSFRS-R-ul), the lower the measured performance of handwriting (r=0.693, 
p<0.001). Due to disease progression in UL, 5 patients were unable to perform 
handwriting at T1 or T2, although could still use ACD for typing. These patients 
had difficulties in grasping a pen but were able to use one finger to select on the 
keyboard or touchscreen.  
Performance in using a keyboard strongly varied among patients due to 
different previous experience of using computer devices (mean=9.2; SD=5.2; 
range: 2.4-18.7 wpm), at baseline assessment. During the period of this study, 
patients’ performance of typing had no significant changes in time, as described in 
Table 3. Interestingly, we could observe that 8 out of 11 patients in G1 with low 
experience (≤3) in the use of computers have improved typing rate, from T0 to T2 
(Figure 20). During the period of this study, decrease in UL function (ALSFRS-R-
ul) did not alter performance of typing (r=0.09, p=0.52), in contrast to performance 
of handwriting, which decreased with UL dysfunction.  
4.3.4 Internet 
Patients in G1 who had internet connection at home were able to learn how 
to use the email and replied to the emails sent by one of the authors (AL), 
independently of previous experience with email. Communicating with family (in 
particular siblings living abroad and grandchildren) was the main motivation 
expressed by patients to use internet.  
4.4 Discussion 
We present a longitudinal study on the effect of early intervention with 
assistive communication devices in quality of life of bulbar-onset ALS patients and 
their caregivers. Most studies regarding the impact of assistive communication on 
the QoL address ALS patients with severe UL dysfunction, but not much research 
focuses on its specific impact when introduced from early stages. 
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4.4.1 Quality of life 
In this study, when investigating on the effect of communication in patients 
and caregivers’ quality of life scores, we cannot ignore that other factors may have 
had impact on these scores; moreover, since we explored several scores and 
subscores of quality of life, statistical significance was not attained considering 
multiple comparisons between the two groups of patients. Nevertheless, our 
results support that communication difficulties affect quality of life and that early 
intervention with ACD has a positive impact on some of its domains.  
Problems in communication were reported as negative factors in quality of 
life, by both patients and caregivers, and some patients and caregivers referred to 
ACD as having a positive impact on their quality of life. Indeed, Körner et al. 
(2012) reported that the use of communication devices improves or stabilizes 
quality of life and mood of ALS patients with dysarthria. Accordingly, in our study 
we observed that in the second assessment, Psychological Symptoms and 
Existential well-being domains of quality of life were higher for patients using ACD. 
However, in the third period of assessment, differences between groups were 
reduced to Psychological symptoms. We hypothesize that, as disease progresses, 
Existential well-being domain of quality of life might be influenced by other 
symptoms related to disease progression. In particular, in this population of bulbar-
onset, patients’ dysphagia had a major negative impact in the period of the third 
assessment.  
In our study, quality of life of both patients and caregivers decreased 
overtime. Further, patients with lower bulbar function had lower quality of life. 
These results contradict other longitudinal studies that demonstrated 
independence of patients’ quality of life on disease symptoms progression 
(Robbins et al., 2001; De Groot et al., 2007; Olsson et al., 2010; Chiò et al., 2004) 
or stability of quality of life with time (Gauthier et al., 2007; Trail et al., 2003). This 
contradictory result may be related to the homogeneity of selected patients in our 
study. In particular, in bulbar onset ALS, rapid progression could influence quality 
of life in the early stages.  
General decrease in caregivers’ quality of life scores, which we observed 
between the baseline and the final evaluation, compares with other studies 
(Robbins et al., 2001; Lo Coco et al., 2005). In our study, the early intervention 
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with ACD had a positive impact on caregivers´ support domain of quality of life, 
indicating an increased feeling of being cared for and supported. Moreover, for 
caregivers in the group of early intervention, patients with higher communication 
effectiveness index had caregivers with higher psychological quality of life. We 
hypothesize that this result is related to a positive experience of support, due to 
training and specific follow-up of patients with ACD, as well as the experience of 
improvement of communication with the patients.  
Caregivers and patients’ quality of life scores were not correlated; they were 
higher for patients comparing with their caregivers. Accordingly, Lo Coco et al. 
(2005) suggest that patients and caregivers do not represent a single 
psychological entity. Following these findings, different motivation and 
expectations for the use of ACD should be considered between patients and 
caregivers, depending on each individual context.  
4.4.2 Caregivers 
A special attention to caregivers is important in intervention with ACD. 
Caregivers have an important role as primary facilitators in the use of 
communication devices (Ball et al., 2005); the use of ACD by patients is strongly 
dependent on caregivers’ support, in particular when patients’ disability is major. In 
agreement to the positive association between the psychological domain of quality 
of life and patients’ self-perceived communication (observed in the group with 
early support) it is expected that caregivers who are supportive of enhancing 
communication will raise patients’ confidence in the use of ACD. Nevertheless, we 
have observed that the initial expectations for the early use of ACD were generally 
lower in caregivers than in patients. Encouragement from researchers or siblings 
was an important factor in raising the motivation of both patients and caregivers, in 
particular those who had no past experience in technology.  
4.4.3 Evaluating the use of assistive communication devices 
One limitation of our study is that we did not quantify the number of 
hours/day of using the selected application in ACD. However, UL performance for 
using the ACD did not drop significantly overtime, even for patients with lower 
ALSFRS-R-ul scores, suggesting its persistent use. Despite the initial slower 
communication performance by typing when compared to handwriting, we 
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emphasize that some patients could still rely on typing using the touchscreen 
access after being unable to perform handwriting and speaking. Therefore, we 
suggest that touchscreen-based ACD preserves better autonomy in 
communication for longer periods than handwriting.  
Interestingly, we could observe improvements in the performance of typing 
in patients with early support for the use of ACD and with previous experience in 
using computers scored as lower than 3 (average age: 65.42±11.94 years). We 
hypothesize that improvement in performance was related to the process of 
memorizing key positions in the keyboard due to the regular use of ACD. Also, 
patients who had internet at home successfully learned to use email 
communication. This result indicates that, in this early period of the disease, 
patients can effectively learn and improve skills for using communication devices, 
independently of the disease’s progression. This period may be particularly 
important for patients with little experience with computer devices.  Another 
limitation of our study is that the selected population had a low education level and 
poor technology training, in general. This could limit generalization of the positive 
results. But, we would expect better or similar outcomes when applying early 
intervention in a more educated population (Czaja & Lee, 2008). Our population 
was formed by bulbar-onset patients, with a typical female gender predominance. 
Women tend to have a lower experience with technology. This later issue was 
associated with poor literacy and low pension income, which could be critical to 
interventions, like the use of ACD. The vast majority of our patients had no access 
to a computer, smart-phone or tablet devices. From our results we consider that 
even in this set of ALS population, timely intervention permit successful learning 
and adaptation to new communication tools, with positive impact on the quality of 
life. 
When studying intervention with ACD, it is difficult to assess how patients 
use the communication tools out of the research environment. Further, we cannot 
reject that, while possible, patients use handwriting jointly with ACD at the very 
early stage. In this study, we considered typing rate improvement and self-
reported communication effectiveness index as outcome measures for evaluating 
the use of ACD. As previously discussed, improvement of typing rate in 
inexperienced patients was most probably due to regular practice in the use of the 
communication device. Besides, patients using ACD reported higher scores in 
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communication effectiveness index, when comparing to patients with no early 
intervention. Indeed, after intervention with ACD, we found that the self-perceived 
communication of these patients was not related to their bulbar functional score. 
This can be explained by the effectiveness of ACD to compensate communication 
difficulties related to speech. In our perspective, it is not important to detail how 
each patient uses communication tools, since it may strongly depend on each 
person and their social environment, but to confirm the impact it has on self-
perceived ability to communicate. For example, some patients reported the use of 
ACD to participate in internet social networks and others just wanted to 
communicate with close family. Accordingly, we suggest that the evaluation of 
intervention with ACD should consider self-perceived ability to communicate an 
important outcome, from early stages.  
4.4.4 Duration of use  
Although there is a growing offer of communication tools based on 
touchscreen tablet devices that can be easily accessed by patients, anticipation of 
UL severe dysfunction raises the question on whether an ALS patient should be 
supported in communication with these devices. As an additional part of this study, 
we investigated on the duration of use of ACD based on touchscreen access, in 
our group of patients. We monitored the use of ACD in 14 of our participants after 
the end of this study, until the end of life or when they were unable to use 
touchscreen ACD due to severe muscle weakness in ULs. These devices were 
used for a mean duration of 11 months (SD=3.4, range: 2-24 months). Eight out of 
the 9 patients who have died were able to use ULs to communicate with the ACD 
(using the touchscreen) until the end of life; these patients had preserved UL 
function for access to a touchscreen-based keyboard, and did not need any other 
access strategy. Even for patients who had fast progression in UL dysfunction, 
shorter use of touchscreen was important for learning how to use assistive 
communication tools. Their transition to alternative access (patients used head 
movements or eye-tracking control), was easily learned and accepted as important 
by both these patients and their caregivers. We suggest that touchscreen access 
is valid for early intervention in communication, as long as communication tools 
are prepared to integrate other access strategies to accommodate UL dysfunction. 
Further research is needed on predictors for upper limb function that are relevant 
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to anticipate the need of new access strategies for the use of assistive 
communication devices. 
4.4.5 From early to late stages 
Research in advanced technologies that allow late-stage patients to 
communicate and control the environment has gained high relevance, indicating 
communication as determinant for patients’ quality of life (Caligari et al., 2013; Lulé 
et al., 2008) in those stages. However, late referral is still described as a common 
reason for low acceptance of technology in late stages of ALS (Brownlee & 
Bruening, 2012; Beukelman et al., 2011). Moreover, patients’ age or intrinsic 
motivation (which may be related to mastery confidence or incompetence fear) 
have been studied as factors influencing performance of ALS patients using BCIs 
(Nijboer et al., 2010; Silvoni et al., 2013) or as general psychosocial factors 
(motivation and confidence) involved in competence to use ACD ( Light & 
McNaughton, 2014). In our study, patients with early intervention for using ACD 
improved skills to use communication devices, particularly in those with low 
experience with informatics and low education. Both patients and caregivers’ 
motivation for using ACD was progressively higher. Text-to-speech and onscreen 
keyboard for writing are valid communication tools both in early and late stages, 
regardless of the need to adapt ACD for replacing UL function. Particularly in fast 
progression, early intervention may reduce negative factors that influence 
acceptance of ACD in later stages and potentially will improve communication in 
overall disease progression.  
4.5 Conclusions 
Our results suggest that assistive communication tools based on touch 
screen-tablet devices (including text input, speech synthesizer and internet 
access) should be introduced in early stages of bulbar-onset ALS, particularly 
when dysarthria score in ALSFRS-R is between 2 and 3. Our study indicates a 
positive impact of assistive communication on quality of life in early stages of 
bulbar-onset ALS, both for patients and caregivers. We suggest that early 
intervention will improve patients’ skills for using communication devices in later 
stages, when more complex alternative access strategies are necessary. Future 
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research is needed to investigate on the effect of early intervention on general 
performance of communication in later stages.  
 
4.6 New findings and their importance under research goals 
We found that ACDs show a strong trend towards a positive impact on the 
QoL on both early-affected bulbar-onset ALS patients and on their caregivers. This 
study was original in two ways:  
(1) we applied a randomized, prospective, longitudinal design to test the 
impact of ACD on quality of life in early affected ALS patients and their caregivers, 
which is contrary to previous studies that included advanced patients very affected 
regarding speech and UL function;  
(2) we demonstrated that early ACD support based on touchscreen input 
can preserve self-perceived communication for longer than handwriting, in bulbar 
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Chapter 5  - Monitoring disease 
progression with assistive 
communication devices: speech and 
typing activity  
Two studies were conducted including the following research goals: (1) to 
explore novel methods to objectively characterize disease progression in speech 
and in ULs function; (2) to test the hypothesis that ACDs can be used as tools to 
remotely monitor ALS progression.  
Typing activity and speech were collected during longitudinal assessments 
of ALS patients, in the same setup as for the study of quality of life (Chapter 4). 
For the purpose of testing this hypothesis with data that would be possible to 
collect in an in-home environment, procedure was designed to be simple and non-
exhausting. Typing activity and speech were recorded with a standard laptop 
computer. Length of recordings (both in speech and typing) was restricted to one 
short and well-known Portuguese 10-word sentence: Tudo vale a pena quando a 
alma não é pequena.  
5.1 Introduction 
Assistive devices usually rely on keyboards (physical or virtual). As disease 
symptoms progress, UL weakness leads to increasing difficulties in using a 
keyboard (either physical or touchscreen-based) until the use of input devices that 
do not rely on UL movements (e.g. eye tracking and brain computer interfaces) are 
needed for communication and environment interaction (Caligari et al., 2013; 
Lightbody et al., 2014). Moreover, speech intelligibility decreases until 
communication using natural speech is very difficult and frustrating (Green et al., 
2013). 
Identification of markers of disease progression is important to monitor ALS 
patients, with potential application in clinical trials (de Carvalho et al., 2005; Simon 
et al., 2014). As previously mentioned in section 1.2, ALSFRS-R is broadly used 
for assessment of ALS symptoms during the course of the disease. This scale 
includes a subscore for UL function (ALSFRS-R-ul) and Bulbar function 
(ALSFRS_R_b), as described in section 4.2.4. In spite that this scale can be 
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reliably administered remotely by patients or caregivers, over the phone or the 
internet by online assessment (Maier et al., 2012), two limitations of this 
assessment tool are addressed in our research: it does not give a continuous 
objective scoring (since it does not rely on physical examinations or instruments 
(Cedarbaum & Stambler, 1997; Tramacere et al., 2015) and it may not be enough 
sensitive to change, considering that it has been criticized for having a relatively 
small slope of decline (Wicks et al., 2009; Traynor et al., 2004). Bulbar motor 
dysfunction starts before perceived changes in speech intelligibility. For example, 
speech rate decreases prior to a perceived impact on speech intelligibility, but the 
first may be a marker for the later, as studied by Ball et al., (2001). In addition, 
results in section 4.3.3 showed that ALSFRS-R may be not sensible to functional 
decline in the use of UL for specific activities related to control of assistive devices 
(mostly involving movements to select, tap or press and release keys).  
The goal of this research was to develop new methodologies intended for 
the design of non-invasive instruments, supported on ACD, for early detection, 
monitoring of disease progression and clinical trial applications. We developed 
methodologies for objective and longitudinal functional assessment of speech and 
ULs, based on simple procedures for recording typing activity and speech. Our 
main objective is to contribute for the development of in-home monitoring tools (to 
be implemented in ACD) that can assist in-clinic assessment of communication in 
patients with ALS. 
5.1.1 Upper limb dysfunction and typing activity 
Typing activity with a computer keyboard has been suggested by Austin et 
al. (2011), as a surrogate for the finger-tapping test, which could be used as a 
continuous in-home tool. Finger tapping test has been widely used in research of 
several neurological conditions, for characterization and quantitative assessment 
of the UL motor function (Bowden and McNaulty, 2013; Shima et al., 2014; 
Buracchio et al., 2010; Jimenez-Jimenez et al., 2010).  
In the present study, we used a simple setup with inertial sensors to explore 
features related to UL function in typing activity. To keep independence of users’ 
experience in the use of keyboards for writing, frequency of typing (analogous to 
tapping frequency in finger-tapping test) was not considered. Alternatively, we 
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analyzed time and movement features related to key press and key release 
actions.  
Study aims related to typing activity were: 
(a) Characterization of UL impairment progression in ALS patients for using 
assistive devices, by analysis of finger movements in keyboard typing;  
(b) Identification of typing activity markers that could provide a new tool for 
disease monitoring. 
5.1.2 Bulbar dysfunction and biomechanical modeling of speech production 
The deterioration of the neuromotor system involved in respiration, 
phonation, swallowing, and lingual and oro-facial muscle function degenerates in a 
rapidly progressing dysarthria. As ALS progresses, speech movements become 
smaller in extent and slower in speed (Green et al., 2013). Perceptual and 
acoustic features of dysarthria in ALS have been well studied (Tomik & Guiloff, 
2010; Bongioanni, 2008).  
Turner et al. (1995) studied the relationship between speech rate, speech 
intelligibility and vowel space area (VSA) in a group of 9 patients with ALS.  These 
authors suggested that VSA was an important component of global estimates of 
speech intelligibility (accounting for 45% of the variance in speech intelligibility). 
The VSA and the Formant Centralization Ratio (FCR) are parameters defined to 
estimate the vowel span range and positioning produced by a given speaker 
(Sapir et al., 2011). In this exploratory study, we assume that the relative deviation 
of VSA and FCR in a specific patient with ALS, from a control or normative 
statistics, may be used to evaluate the distortion of the formant space, in terms of 
independent formant span ranges (∆F2 vs ∆F1). This deviation can be expressed 
as a vector in the formant space showing speech deterioration related to disease 
progression. We use a method based on speech articulation biomechanical 
modeling, from the level of signal processing to neuromotor activity inference 
(Gómez-Vilda et al., 2011). Estimated parameters in common speech are 
associated to specific neuromuscular complexes involved in articulation, more 
specifically the masseter, the stylo-glosus and the genio-hyo-glosus muscles - as 
described in Gómez-Vilda et al. (2015).  
We performed longitudinal study cases in patients with ALS, to study the 
evolution of the vowel space as disease progresses. We aimed at exploring early 
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detection and monitoring of speech dysfunction in ALS, based on running speech 
and low-cost voice recording instrumentation. 
5.2 Materials and Methods 
5.2.1.1 Materials  
For data collection of finger movements in keyboard typing, we used a 
wireless 4-channel acquisition system with a 3-axis accelerometer sensor (range 
±3 g, with a relation of 300 mv/g at the output) and a sample rate of 1KHz. The 
sensor was placed on the posterior part of the index finger of the dominant hand, 
as depicted in Figure 21. There was one exception: one patient used the non-
dominant hand due to severe dysfunction of the right upper limb. Data was 
acquired via Bluetooth to a common laptop computer, to be processed offline. A 
second laptop was used for the typing tasks. Due to its very low weight, the sensor 
did not interfere with the finger typing activity.  
For data collection of speech, we used the laptop where patients performed 
the typing task. Voice was recorded at 44 kHz and 16 bits. 
5.2.1.2 Methods  
ALS patients were assessed at study entry and every 2-6 months for a 
variable period depending on disease progression. Assessments were made 
during clinical appointments. At each session, patients were asked to record 
speech: reproducing a familiar Portuguese 10-word sentence “Tudo vale a pena 
quando a alma não é pequena” (Figure 21). Then, the accelerometer was placed 
on the participant´s index finger. Patients were asked to type the same 10-word 
sentence using just the finger with the accelerometer (Figure 21). All tasks were 
recorded throughout accelerometer signal acquisition, a video camera and a log 
text editor. A complete assessment session had the duration of 20 minutes. In the 
first assessment we asked each participant to classify previous experience in 
using a computer by applying a Likert-type classification of 0 (I have no 
experience) to 5 (I am very skilled in the use of computers).  
Typing and speech analysis was blind to the functional rating scores of the 






          
 
Figure 21 - Experimental setup (up) speech recording in a simple voice recording system included in 
a common laptop. (down-left) An accelerometer was placed on the typing index finger of the subject. 
Accelerometer was connected to the acquisition module. Data was sent via bluetooth connection to a 
computer where it was saved. Participants did the typing tasks in a laptop using a simple text editor. (down-
right) The three axes of the accelerometer sensor were measured, as illustrated. 
 
5.2.1.3 Participants 
Nineteen ALS patients were consecutively recruited, with the following 
criteria: probable or definite disease according to the revised El Escorial criteria 
(Brooks et al., 2000), bulbar onset disease (as bulbar-onset patients presenting 
with dysarthria were previously included in a study evaluating the impact of 
communication devices in quality of life), no other neurological disorder (in 
particular no clinical signs of dementia or polyneuropathy), absence of mechanical 
limitation using hand or fingers (as associated with arthritis, edema or pain) and 
agreement to participate. The joint Ethics Commission of the Centro Hospitalar 
Lisboa Norte and Faculdade de Medicina de Lisboa approved this research and 
patients gave written informed consent. Four of these patients with low perceived 




A total of 26 controls were included: six patients with other neuromuscular 
disorders causing moderate UL weakness (3 with demyelinating neuropathy with 
predominant motor impairment and 3 with spinal muscle atrophy) and 20 healthy 
subjects. The six patients with other neuromuscular disorders had ALSFRS-R-ul 
scores between 9 and 11.  
For reference of speech data, two of the healthy subjects were recorded 
under the same conditions described for the patients.  
5.2.1.4 Typing signal and outcome measures from typing activity 
For feature extraction we used the Euclidean norm of the 3-axis (ax,ay,az) 
acceleration signal (Equation 1).  
 
(Equation 1)        
 
  (m/s2)                    
 
We extracted four features from the acceleration signal (related to finger 
typing a keystroke), as described in Figure 22: mean keyhold time (t_hold) - 
mean time spent in holding down each key, in a typing task; time to press (t_p) – 
mean time spent between tapping a desired key and pressing it down, in a typing 
task; acceleration to press (accpress) – mean acceleration in the movement of 
pressing each key during the typing task; acceleration to release (accrelease) – 













Figure 22 - Recording of finger movements in typing activity. (top) User finds and points to the 
desired key (A), touches the desired key (B), then presses it down (C) and finally, the user releases the key 
(D). (middle) Signal showing 20 seconds (17 keystrokes) of typing activity from a healthy participant. Vertical 
dotted lines indicate events of pressing (C) and re- leasing (D) a key. (bottom) Signal showing two 
consecutive keystrokes. Features extracted from the accelerometer signal are marked: t_hold: time from C to 
D, while user holds down the key; t_p: time delay between touching the key (B) and pressing it (C); accpress: 
maximum acceleration at key press (C); accrelease: maximum accel- eration at key release (D). 
 
5.2.1.5 Phonation modeling and outcome measures from speech 
Recordings were originally saved with 44kHz sampling rate and 16 bit 
resolution, on the laptop. For feature extraction of speech recordings, we used the 
formant-like pattern detection on LPC spectrograms produced from the speech 
signal using a Phonation Model Inversion (Gómez-Vilda et al., 2011). Recordings 
were undersampled at 8kHz before being processed; formant positions F1-F2 in 
each 2 ms were extracted using a 11-pole LPC lattice-ladder inverter to separate 
vocal tract and glottal source components (Gómez-Vilda et al., 2013). Segments 
with no phonation were removed from the estimations. A synoptic vowel triangle 
94 
similar to the one defined in Figure 26 was produced from the F1-F2 positions 
obtained from each utterance. 
Outcome measures, inferred from this Phonation Model Inversion, were: the 
vowel triangle (F1-F2), the formants span (∆F1 and ∆F2) in relation to an ideal 
vowel triangle, the modulus of the normalized formants span (MNFS), the vowel 
space area (VSA) and the formant centralization ratio (FCR) (see Appendix A). 
5.2.1.6 Statistical Analysis 
Pearson correlation was used to study association between variables. For 
the analysis of typing activity, unpaired and paired t-Test for dependent variables, 
and one-way ANOVA were used to test differences between groups. Repeated-
measures ANOVA was used in longitudinal analysis (three assessments) of each 
patient. For ANOVA, post-hoc analysis with Tukey HSD was used to find 
significant differences between pairs. A p-value lower than 0.05 was considered 
for statistical significance. 
5.3 Results 
Median age of the ALS population was 64 years (ranging from 38 to 81) and 
median disease duration was 14 months (ranging from 2 to 34). Healthy control 
subjects were matched for age and gender (p>0.05). Most ALS patients (84%) 
were women, due to specific clinical characteristics of this group of ALS patients 
(bulbar onset). Twelve healthy controls (60%) and 5 controls with other 
neuromuscular disorders had poor experience in using computers (score ≤2). Ten 
ALS patients (62.5%) were using a personal tablet or computer device for assistive 
communication, due to speech difficulties, during this study. ALS patients were 
followed during 2 to 20 months, in intervals of 2-6 months (2 to 6 assessments), 
the period of regular clinical appointments. Number of assessments performed for 
each patient varied due to progression rate of speech or UL function (fast 
progressors lost ability to type a few months after entry) or death (or late stage 
conditions).  
5.3.1 Analysis of typing activity 
Table 5 shows a summary of the ALS patients and assessments. Due to 
variability between patients in number of assessments, we selected 2 to 3 
assessments of each patient. For patients with more than three assessments, we 
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selected the baseline, the last and the assessment closer to the mean time within 
first and last assessments. 
 
Table 5. Characterization of patients and longitudinal assessments used for the study of typing activity 
P# Experience(a) ACD T_ASSESS Total time(b)   ALSFRS-R ALSFRS-R-ul Group 
1* 3 Y 4 12.5 26/17/14 10/7/5(c) W 
2 4 N 2 4.2 15/5 8/3(c) W 
3 0 Y 2 5.9 17/10 5/0(c) W 
4 2 Y 3 5.4 36/31/25 12(c)/11/10 N 
5* 2 N 5 13.2 30/22/15 11/10/6(c) W 
6 0 Y 6 14.9 36/27/22 12(c)/12/10 N 
7 4 N 2 2 35/31 12(c)/9 N 
8 0 Y 2 6.9 24/14 9/4(c) W 
9 4 N 3 5.6 6/7/3 3(c)/3/0 W 
10 3 Y 4 8.7 20/17/14 11(c)/9/8 N 
11 0 Y 6 19.7 32/16/14 12(c)/8/7 N 
12 4 Y 6 15.6 27/23/13 12(c)/10/8 N 
13 0 N 3 7 29/27/25 12(c)/12/12 N 
14* 0 Y 5 16 36/31/20 12(c)/12/9 N 
15 1 N 2 2.1 19/15 7/4(c) W 
16* 2 Y 3 7.6 26/28/23 9/9/7 - 
17 4 Y 2 3 22/15 9/2(c) W 
18 2 N 3 7.7 12/6/2 4(c)/1/0 W
(d) 
19 2 N 2 6.2 32/27 12(c)/9 N 
        
ACD: using an ACD (Yes or No); T_ASSESS: Total number of assessments; ALSFRS-R = 
ALSFRS-R score (from 0 to 48, normal); ALSFRS-R-ul = ALSFRS-R upperlimbs subscore (from 0 
to 12, normal); N: nALS-normal UL (no UL dysfunction when performing typing task); W: wALS 
(marked UL dysfunction when performing typing task) 
* Patients evaluated for speech analysis 
(a) Experience with computers rated by the patient (0:min to 5:max). 
(b) in Months. 
(c) Assessments that were considered for comparison between groups Normal/ Weak UL function. 
(d) This patient used left hand for typing – as ALSFRS-R-ul was not sensitive to this function of the 
left hand, we followed video analysis to classify typing performance group. 
 
 
Outcome variables were calculated for each typing task as the mean value 
of all keystrokes. Average number of keystrokes performed in each typing task 
was 38.1 (SD=10.6) (variation on the number of keystrokes for typing the same 
10-word sentence depended on the spelling errors, missing spaces and 
punctuation). 
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5.3.1.1 Test-Retest Reliability 
Fourteen participants performed a second task: typing a free sentence (like 
writing their names or what they did during that morning). This second task was 
performed in the same evaluation session, after typing the standard 10-word 
sentence. Number of keystrokes in the second task was 31.6 (SD=18.62). 
Measurements obtained from the first task were highly correlated to those 
obtained in the second task, as presented in Table 6.  
Table 6. Test-Retest reliability comparing performance with a standard sentence vs free sentence 




R Paired t-test 
t_hold 221.49±94 233.40±108.44 0.963* p=0.210 
Accpress 20.71±8.83 22.31±10.10 0.957* p=0.093 
Accrelease 13.26±3.84 13.58±4.09 0.841* p=0.635 
t_p 103.14±56.11 115.82±65.90 0.908* p=0.062 
R = Pearson product-moment correlation coefficient 
* p<0.001 
5.3.1.2 Test independence of user experience 
To test the independence of previous user experience (in the use of 
keyboards) on the measured variables, we tested healthy controls and ALS 
patients with no or mild UL dysfunction. Those who had a good experience in 
using computer or assistive communication devices (score >2, 11 subjects) were 
compared to those who had low experience (score ≤2, 13 subjects). There were 
no significant differences between both groups (Table 7).  









t_hold 182.10±80.57 179.32±65.69 p=0.920 
Accpress 24.17±9.15 21.33±8.99 p=0.425 
Accrelease 16.05±6.37 15.46±4.59 p=0.779 
t_p 63.13±55.21 60.06±48.46 p=0.885 
 
(a) 4 healthy controls and 7 patients; (b) 4 healthy controls and 9 patients. 
 
5.3.1.3 Sensitivity of measurements to test progression 
To evaluate the sensitivity of measurements in evaluating the progression 
of UL dysfunction, we compared data from patients with low and severe 
dysfunction in UL. We defined 2 subgroups of ALS patients: normal UL (nALS) - 
patients with no significant UL dysfunction (ALSFRS-R-ul subscore >10) and weak 
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UL (wALS)- patients with marked UL dysfunction (ALSFRS-R-ul subscore ≤ 6). All 
the assessments of each patient were classified in one of these subgroups. When 
one patient was classified in more than one group, the wALS was chosen for 
statistical analysis (indicated in Table 5).  
 
Table 8. Results from typing activity distributed by classification of upper limb dysfunction. Description of 
outcome variables (mean±standard_deviation). 
 HE (n=20) NM (n=6) nALS (n=109) wALS (n=9) p-value 
t_hold 
(ms) 110.5±43.79 222.86±37.35 173.26±70.80 304.88±40.35 







(m/s2) 25.71±6.49 16.11±7.40 29.83±6.49 13.08±6.69 







e (m/s2) 17.99±4.66 11.16±6.35 18.30±3.56 10.07±4.57 







(ms) 26.11±25.36 15.56±3.83 52.83±35.27 161.13±76.20 






HE: healthy controls; NM: controls with other neuromuscular diseases; nALS: ALS patients with 
normal UL function; wALS: ALS patients with marked UL dysfunction. 
 
5.3.1.4 Keyhold time 
Mean values of t_hold, calculated for each group, are described in Table 8. 
Comparisons between groups indicate significant differences between healthy 
controls and all groups of patients (p<0.01) and between wALS and the other 
groups (p<0.01) (Figure 23). Mean t_hold from patients with other neuromuscular 




Figure 23 - Mean values of outcome variables in the different groups: HE (healthy participants); NM (other 
neuromuscular diseases); nALS (ALS patients with normal UL function) and wALS (ALS patients with marked 
UL dysfunction). 
 
5.3.1.5 Longitudinal analysis of keyhold time 
For the longitudinal analysis of t_hold in patients with slower progression in 
UL, we selected a subset of patients with three assessments (N=12) (Table 5). We 
observed significant differences in t_hold between assessments (p=0.008). 
Increase in t_hold was found between the first (mean difference of 64.0 ms, 
p=0.03) or middle (mean difference of 44.1 ms, p=0.04) and the last assessment, 
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but not significant between the first and the middle assessment (mean difference 
of 19.9 ms, p=0.211). Fig. 4 represents t_hold and ALSFRS-UL scores obtained 
for the three assessments.  
 
 
Figure 24 - Longitudinal assessments. Plots represent median values of t_hold and ALSFRS-UL 
scores, in each of the three assessments.  
 
5.3.1.6 Delay to press 
As ALSFRS-R-ul decreases, there is an increasing delay between touching 
the key and the movement for pressing it down (t_p). Figure 25 illustrates this 
increasing delay observed in 9 months on one patient and comparing it with a 
healthy control. This delay to press down the key (after touching it) was higher in 
the wALS group compared with nALS and controls (p<0.01) – Table 8 and Figure 
23.   
5.3.1.7 Acceleration in movements for pressing and releasing each key  
Mean values for acceleration at key press (accpress) and key release 
(accrelease) are described in Table 8. Both acceleration at key press and at key 
release decreased with UL dysfunction: accpress and accrelease were 
significantly lower in the group of wALS comparing with healthy controls or with 
patients with normal UL (p<0.05). We found no differences between healthy 
controls and nALS; patients with other neuromuscular disorders had lower 
acceleration amplitude for releasing keys, when comparing to ALS patients with 
normal UL (p<0.05) (Figure 23). 
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5.3.2 Analysis of speech production 
Speech of four ALS patients (all were women and are marked in Table 5) 
was recorded in 3 to 5 evaluation sessions, separated by 2 to 6 months intervals. 
Healthy controls were selected from the control set: two women with 36 (CF36) 
and 63 (CF63) years old. An ideal vowel triangle inferred from the control subject 
CF36, was defined for comparisons between different assessments of each 
patient (Figure 26). 
 
 
Figure 25 - Delay for pressing and releasing. Plots represent one keystroke in one healthy control (in 
dotted line) and two different assessments of the same ALS patient. There was an increasing delay in 
pressing the key (t_p) and for releasing it (t_hold) from the first assessment (1) to the last assessment 
recorded 9 months later (2). Acceleration also decreased from (1) to (2), either in key press and key release. 
Gray dotted lines indicate the events marked according to Figure 2 and the group of UL dysfunction. The three 




5.3.2.1 Formants (F1 and F2) and Vowel Triangle 
Results for each recording were compared against the ideal vowel triangle. 
Percentage of formant span reduction (∆F1n and ∆F2n) normalized with respect to 
the control CF36 are given in Table 9. 
 
 
Figure 26 – Formant positions on the F1/F2 Vowel Triangle of CF36. Vertices of the idealized vowel 
triangle are defined by thin circles (Vbl,Vtl,Vcr). 
 
The first recording (0) of PF1 shows a displaced and enlarged span for F1 
(∆F1n=120%), and a much-compressed span for F2 (∆F2n=47%). Recordings (1) 
and (2) show a moderately compressed ∆F1n (84% and 68%) whereas the ∆F2n 
is also shrinking progressively (35% and 27%). These results would indicate, 
according to the biomechanical model of speech presented in Appendix A, a 
severe loss of activity in the stylo-glosus and genio-hyo-glosus muscles, whereas 
jaw control is moderately impaired. 
 
Table 9. ∆F1/∆F2 in % relative to the control CF36, for each recording of the four ALS patients. The column 
under each patient (PF#) represents: (ALSFRS-R-B; Months after baseline evaluation) %∆F1/%∆F2. 
 CF36 CF63 PF1 PF2 PF3 PF4 
 Age 36 63 38 64 77 79 
 Record.0 100/100 69/80 (6;0) 120/47 (9;0) 92/47 (8;0) 84/80 (11;0) 72/68 
 Record.1 - - (5;4) 84/35 (6;3) 61/46 (5;3) 66/62 (9;6) 67/88 
 Record.2 - - (3;6) 68/27 (6;5) 60/58 (5;7) 80/51 (6;10) 72/44 
 Record.3 - - - (6;8) 54/28 (5;10) 55/37 - 
 Record.4 - - - (6;11) 50/29 (2;13) 39/23 - 
 
CF36: 36-year-old healthy control; CF63: 63-year-old healthy control; PF#: Patients 
(from 1 to 4) 
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The evolution of case PF2 has a larger number of recordings. It may be 
seen from the first recording (0) that the degree of affection of F1 is moderate 
(92%), its progression being apparently irreversible (61%-60%-54%-50%). On its 
turn the affection of the SG-GHG is already strong (47%) in the first recording (0) 
whereas progress is not steady in recordings (1)-(4), going through 46%-58%-
28%-29%.  
The third study case corresponds to an older patient (PF3, 77 years). The 
evolution for ∆F1n is 84%-56%-80%-35%-29%, which indicates a moderate initial 
affection, but a fast progression in the last recordings. The evolution of ∆F2n is 
80%-62%-51%-37%-23% is indicating a progressive control loss of the stylo-
glosus and genio-hyo-glosus muscles, and confirms the deterioration of jaw and 
tongue articulation functions in a similar way.  
The last case corresponds to a 79-year old female (PF4). The progression 
for ∆F1n is 72%-67%-72%, which indicates an initial relative deterioration of the 
MS muscle, which was not progressing significantly during 11 months; on its turn 
the progression for ∆F2n is 68%-88%-44%, which indicates an irregular slow 
progression to articulation deterioration.  
5.3.2.2 MNFS, VSA and FCR 
The evolution of MNFS and VSA for the four cases studied, compared with 
the two controls CF36 and CF63 is described in Figure 27 and Figure 28. It may 
be seen that all patients show a progressive decrease in MNFS and VSA, from the 
first to the last recording. MNFS was positively correlated to VSA (r=0.955, 
p<0.05) and inversely correlated to FCR (r=-0.913, p<0.05), as FCR is increasing 





Figure 27 – Vowel space area for recordings from the four study cases presented compared to 
controls CF36 and CF63. 
 
     
Figure 28 – (left) Modulus of the normalized formant span for recordings from the four study cases 
presented compared to controls CF36 and CF63. (right) Formant Centralized Ratio for recordings from the 
four study cases presented compared to controls CF36 and CF63. 
 
5.4 Discussion 
5.4.1 Markers of progression in typing activity  
The main aim of this study was to quantify UL impairment in ALS patients 
by using a keyboard. In addition, we aimed to identify a sensitive marker that could 
be explored as a tool to monitor UL functional impairment over disease 
progression.  
Inertial sensors were used for movement recording, with the advantages of 
being easy to place on the finger and without causing movement constraints. This 
kind of sensors has been proposed for motion tracking and quantitative 
assessment of UL function in many conditions (Uswatte et al., 2000; Lyons et al., 
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2005; Zhou et al., 2008; Bai et al., 2014). For our purpose, we used a simple setup 
with one miniaturized accelerometer, for recording finger activity related to actions 
of tapping, pressing and releasing keys in a short typing task.  
We observed that the mean delay between pressing and releasing keys 
(keyhold time – t_hold) increased in parallel with greater UL dysfunction. 
Moreover, in ALS patients with preserved UL function, this time was already 
increased. Possibly, this measurement could be a sensitive marker in early stages 
of ALS and a useful tool to monitor UL dysfunction over disease progression.  
Delay to press (t_p) is apparently not sensitive to detect early changes in 
ALS patients. Progressive UL weakness causes a significant increase in t_p when 
UL impairment is marked. However, this increasing delay for pressing a desired 
key is particularly relevant for functional assessment, since lack of efficacy to 
press down a key or a button (e.g. bed alarm switch) is often the reason for 
initiating support with the use of special interfaces for control of assisted devices. 
Mean acceleration of movements to release and press the keys were not 
sensitive to detect early changes in ALS patients with normal UL function, but did 
show significant decline over disease progression (UL dysfunction). Furuya & 
Altenmüller (2013) also found an association between duration of focal hand 
dystonia in pianists and slower and weaker tapping in piano keys. 
For the aim of this work, inter-key rate and its variability were not 
considered, despite of interesting similarity of these variables with finger-tapping 
tests. Decline in finger tapping speed in ALS, as observed by Kwan et al. (2013), 
could not be tested with our method as we found considerable variations between 
patients. Time between two different keystrokes was much dependent on users 
experience with computers and would have to be tested in overlearned tasks 
(Austin et al., 2011).  
Learning factors, as already described by Jobbágy et al. (2005) as a bias 
for finger-tapping test, must be considered in our study, since patients repeated 
the same typing task in more than one assessment. Nevertheless, results were 
robust to the influence of learning factors. We observed no differences due to 
previous user experience in using computers. Moreover, if a learning effect 
existed, it would be expected that users would improve performance in later 
assessments, due to increasing confidence on the task. On the contrary, patients 
tended to increase delays related to key press and release.  
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Although patients with clinical signs of dementia were excluded, we cannot 
exclude the influence of cognitive and behavioral factors. For example, we could 
identify some patients who often gesticulated with the hands during the task, 
especially those with severe dysarthria, as a way to communicate. Also, some 
patients were depressed or unconfident. However, other patients were 
enthusiastic in performing the tasks. Nevertheless, results from test-retest 
reliability, test of independence of user experience and longitudinal analysis of 
each ALS patient, raised confidence in our results.  
5.4.2 Markers of disease progression in speech 
Despite the low number of case studies (N=4) of this exploratory study, it is 
expected that the present methodology contributes to estimating ALS bulbar 
involvement, using quantitative and continuous evaluation techniques.  
 Both VSA and FCR are well-accepted parameters related with articulation 
degradation in Parkinson Disease (Sapir et al., 2011). The present cases show 
that these coefficients are well correlated with normalized formant spans, which 
are good indicators of neuromotor activity decay both in tongue and in jaw 
(Jürgens, 2002). In general, it may be said that the degree of affection observed in 
the stylo-glosus and genio-hyo-glosus muscles is always strong in the first 
recording (when bulbar dysfunction is already present), whereas the degree of 
involvement of the masseter muscle does not seem so significantly affected 
initially.  These results are according with Yunusova et al. (2008) who found, in a 
study with 9 patients with ALS, impairment of articulatory vowels speed more 
consistently present in movements of the tongue and, occasionally, of the jaw. In 
agreement, it has been studied that F2 slope reflects changes in tongue function 
with disease progression and it is linked to speech intelligibility (Yunusova et al., 
2012).  
A clear explanation for cases where articulation affection seems to be 
reversed (recording 1 in PF1, recording 2 in PF2 and PF3) should be further 
investigated. In future studies it is important to determine if the apparent recovery 
is reliable enough or is due to artifacts. A possible cause could be due to the 
presence of artifacts in the estimation of the pair datasets {F1(n), F2(n)}. 
Nevertheless this explanation does not seem consistent, as vowel triangles are 
estimated on large data distributions. For instance, as illness progresses longer 
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recordings are expected for the same sentence. Besides the expected decrease of 
speech rate, patients tend to speak slower to improve speech intelligibility, ranging 
in our sample from 3 s to 10 s, approximately, to say the same sentence. This 
means that at least from 1500 to 5000 formant pairs {F1(n), F2(n)} were available 
to build quantile statistics. It does not seem plausible that quantile estimates would 
be affected by large artifacts, which are not apparent in vowel triangle plots, as 
these estimates are considered robust to outliers.  
5.4.3 Age and gender 
Age and gender are relevant factors in studies of motor control (Ashendorf 
et al., 2009). Aging leads to reduced motor performance, with a decrease in 
movements’ speed (Bowden & McNulty, 2013; Campbell et al., 1973; Darling et 
al., 1989; Seidler et al., 2010). As a limitation of this work, due to specific 
characteristics of bulbar onset ALS patients, most patients were women above 60 
years. Healthy participants were also mostly women in the same age group of ALS 
patients, but further investigation with a more heterogeneous group of ALS 
patients is necessary to validate results.  
Concerning speech analysis based on biomechanical modeling, a ground 
reference is lacking, as patients were not evaluated prior to developing the 
disease. We chose a young control as reference for longitudinal comparisons in 
our study; however, the age of the controls is a controversial fact. Our choice was 
based on two arguments. Firstly, our elder control showed span reduction, which 
is also found in patients. We can speculate that this could be due to normal 
progressive voice aging processes or to unknown neurological abnormality under 
development. Secondly, young patients cannot be excluded from the analysis, no 
matter how seldom these cases may occur.  
5.5 Conclusions 
Considering ALS, the recording timeline is short, as the disease 
progression may be rapid and clinical assessments are limited to periodic 
appointments in the hospital settings.  
Electronic assistive devices for communication are used by a large number 
of ALS patients. This fact can be further explored as a tool for in-home monitoring 
of disease progression, particularly for assessment of Communication. Functional 
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evaluation of the upper limbs, measure of key hold time can be implemented just 
with software applications in electronic assistive devices. These devices can also 
support recording tools to continuously monitor running speech, even prior to 
communication difficulties.  
The methodology proposed in our study can be applied to the study of other 
progressive neurological conditions that affect speech or UL movements, such as 
Parkinson Disease. Using assistive devices as clinical monitoring tools has the 
advantage of collecting data remotely and non-invasively, in patients’ natural 
environment, on a continuous assessment. 
5.6 New findings and their importance under research goals 
We explored novel methodologies to quantitatively monitor UL and speech 
dysfunction in ALS, out of the clinical settings. Results from this study broaden the 
classical perspective of ACD as technologies with the single purpose of improving 
communication related to speech dysfunction. Conversely, we introduced a novel 
perspective on the potential contribution of ACD to the quality of life in ALS: we 
demonstrated that, in complement to its importance in improving communication, 
these technologies can be further explored for in-home clinical support, as tools to 
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Chapter 6  - Communication during 
stages of severe dysfunction: 
development of a new device to 
assess novel input signals 
6.1 Introduction 
In late stages of ALS progression, patients may experiment pervasive 
muscle weakness, with few functional body sites to access to communication 
devices. Patients may live at home or may have moved to palliative care settings, 
and spend most of the time lying in bed or in a comfort chair. In reference to 
severely disabled ALS-patients and on the use of BCIs, Birbaumer (2006) 
suggests “a general underestimation of the positive attitudes in this group of 
patients”. In Chapter 4, we suggested that improvement of quality of life was 
associated to a better self-perceived communication effectiveness of the patients. 
Moreover, effective strategies that support patients in maintenance of their social 
network, even in later stages, are needed to cope with the disease (Lulé et al., 
2009).  
Even the most severely impaired patients can benefit from communication 
tools (using specific input devices) to extend their communication functions to 
receive information, participate in social networks and make decisions (Light & 
Gulens, 2000; Nijboer et al., 2010; Smith & Delargy, 2005; Hossler et al., 2011). 
As illustrated in Figure 29, when using ACD, patients can establish social contacts 
beyond very simple “yes/no” responses. Appendix C includes texts extracted from 
interactions made by patients using ACD, during our research, either for 
interaction with family or caregivers, as also with medical doctors. 
Important factors for the success in assistive communication at these late 
stages should not be ignored: previous experience on using communication tools, 
easiness and robustness of assistive technologies, the motivation of the patient 
and the motivation of the caregiver to support the use of ACD (Ball et al., 2005; 
Beukelman et al., 2011; Londral et al., 2009; Brownlee & Bruening, 2012). 
However, when patients experiment general severe dysfunction, the most 
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important in supporting communication is to have input devices that can effectively 
capture input signals from the patient. 
 
 
Figure 29 – One patient participating actively on decisions regarding technology adjustments. She is severely 
impaired (no speech and few residual movements in the head) and was using a head-switch as input device 
(scanning method).  
  
Input devices that allow patients with severe physical dysfunction to access 
ACD are of utmost importance in this context. Finding the right input devices that 
fit to the physical conditions of the patient, and enabling him or her to efficiently 
generate input signals to access to an ACD, is sometimes a difficult task due to 
general muscle weakness. Input devices that can be used by patients in these 
conditions are described in section 2.3.2. Undoubtedly, recent development of 
eye-tracking technologies introduced important tools for patients in these 
conditions. However these must not be considered unique solutions. In fact, as 
already described in section 2.3.2.1, eye movements may be difficult to control in 
certain conditions.  
Biosignals captured from sensors placed on the body have been explored 
in various ways to access to communication tools. These have the advantage of 
capturing data directly from the body, reducing patients’ effort to control an 
external input device. Brain activity with EEG and other non-EEG signals have 
been extensively studied as input devices for ALS patients who are severely 
disabled, as is described in section 2.3.2.1. However, there are limitations in 
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existing input devices that are based on these biosignals: (i) Setup is complex and 
learning takes a long training process. Considering patients with severe 
neurological involvement, complexity may limit patients’ motivation (Nijboer et al., 
2010). Moreover, the use of ACD at these stages is closely dependent on 
caregivers’ support, which is hard to achieve if the technology is difficult to setup 
and learn, as previously discussed in Chapter 4. (ii) Lack of flexibility to use 
different sources of input signals in the device. If there is more than one possible 
input signal, an assessment tool could study those input signals that maximize the 
flow of information with the minimal physical and cognitive workload for the user 
(Abascal, 2008). Especially in progressive conditions, as it is the case of ALS, 
input devices should dynamically adapt to physical and psychological stages of the 
patients, along the course of the disease (Londral et al., 2009; Beukelman et al., 
2000). (iii) Many of the experimental results in the development of input devices for 
the disabled are obtained from non-disabled participants. Research where the 
target population participates can reveal usability factors that may be determinant 
for optimal design and effectiveness, when applying these technologies (Clarke et 
al., 2011).  
The aim of this study was two-fold: (1) to develop a tool to assess new input 
signals for patients with very few residual movements, which can be used for 
communication; (2) to develop an input device based on the possibility to use 
various body sensors and underlying biosignals, avoiding the aforementioned 
limitations of other studies.  
6.2 Materials and Methods 
6.2.1 Design Requirements 
Kintsch and Depaula (2002) have enumerated four important aspects to be 
considered in the development of any ACD: 1) it must be customizable; 2) it 
should be simple enough to set-up, customize and use; 3) it should be durable and 
robust; and 4) it must accommodate user’s preferences, namely adapt to the 
users’ environment and social context.  
Considering these guidelines, we developed a new input device with the 
following design requirements:  
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a) It supports different sources of input signals (biosignals), to accommodate 
users’ characteristics; 
b) It must be simple to setup and use in the daily environment of the user; 
c) It should be wireless and adaptable to different body sites, with reduced 
positioning constraints and flexible to follow progression of the disease symptoms; 
d) It must be easy to learn (considering patients and caregivers) and have minimal 
additional setup. 
6.2.2 System Description 
6.2.2.1 General overview 
We developed a platform that receives input signals from simple body-
triggered activations. The input signal (voluntarily controlled by the user) is 
detected by the sensors (placed on the body) that collect the underlying 
biosignals, and transmit them via Bluetooth® to the computer. Signals from the 
sensors are then processed in real time to detect voluntary commands (i.e. 
voluntary body-triggered input signals). When any command is detected, the 
software emulates a keystroke (for example, to control a virtual keyboard using a 
scanning method) or an input command to assistive communication software. 




Figure 30 - Block diagram of the proposed system: (1) Data acquisition - user activates the sensor generating 
input signals; (2) Signal processing - input signal is sent via Bluetooth to the computer and processed to 
generate commands; (3) Switch-based control - when an event is detected, the system sends a command to 
an assistive communication software (e.g. a virtual keyboard) 
 
6.2.2.2 Data Acquisition 
For body signals acquisition we used a commercially available system 
(BiosignalsPlux™) with 4 analog channels. This system collects biosignals from 
different types of sensors and sends these signals via Bluetooth® wireless 
transmission to a base station (a computer). Its wireless transmission range of up 
to 100m is appropriate for the purpose of an input device. This system was setup 
for a sampling rate of 1000Hz and 12-bit resolution per channel. 
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6.2.2.3 Different sources of biosignals 
For our input device, we focused on three different body sensors, namely: 
sEMG (gain:1000; CMRR: 110dB; passing band filter: 25-500Hz; input impedance 
>100MOhm), accelerometer (ACC) (3-axial MEMS; range: ±3G), and force 
sensitive resistor (FSR) (range: 0-10Kg; response time <5µS).  
6.2.2.4 Signal Processing 
After collecting the input signal (biosignal), this is processed through an 
algorithm to generate a control signal. Online detection of commands is based on 
a threshold value for the amplitude of the control signal, which is defined in the 
calibration procedure. Input signal, control signal and threshold can be visualized 
on the screen, as depicted in Figure 31. 
Calibration. Before patient starts to control the system, there is a simple 
calibration procedure, where the user is asked to stay for 5 seconds at rest 
position. The power of the input signal is extracted from this “signal at rest” by 
calculation of the mean value of the input signal for the 5 seconds (5000 samples, 




xi : magnitude of the signal in sample i 
  
 
Treshold value (Th) for the detection of commands is defined in Equation 3, 
as the power of the input signal (as defined in Equation 2) plus the standard 
deviation error of the signal multiplied by a scale factor N, which we defined 
depending on the type of input signal used. This value can then be manually 
adjusted by the user, after the calibration procedure.	
 
(Equation 3)  
 
Control signal: algorithm of variance. When a user makes a voluntary 
activation, the input signal (movement acceleration, muscle contraction, or force) 
shows a corresponding variation (increase) in amplitude. For example: if a user 








Th = power(signalrest)−N × stdev(signalrest)
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approach, the variance of an input signal contains information about voluntary 
control of the signal. To process the control signal, we used the maximum-
likelihood estimate of the local variance (Equation 4), computed for the windowed 
signal parts, in real time (Bonato et al., 1998). This function is analogous to a 
moving average window, except for a square term, which increases the difference 




xi : magnitude of the signal in sample i  
n: number of samples defined for a data window  
 
Detection of commands. The onset of a command is detected as the first point in 
the control signal that surpasses the predefined Th for a minimum interval of 
100ms. This interval was defined to filter sporadic (involuntary) activations. Figure 
31 illustrates the detection of slight movements using an accelerometer. 
Variance analysis is particularly effective to detect voluntary activations for sEMG 
signals (Choi & Kim, 2007b). Further we found that the variance algorithm can be 
generalized to detect voluntary activations with other input biosignals. This 
algorithm was then used in our system for all types of studied input signals 
(accelerometer, electromyography and force). 
6.2.2.5 Visual Biofeedback  
We developed software for online visualization of input signal and control signal. 
Users can then visualize both signals in real time, learn how to voluntarily activate 
the input signal and how to generate commands, using biofeedback strategies 
(Figure 31). When the control signal rises above the line of Th, there is a visual 






























Figure 31 - Visual biofeedback window developed for the present study. Both body signal and control 
signal (from the variance algorithm) are visually presented to the user. User learns to control the body signal 
by watching it on the screen. The objective is to raise the signal above the horizontal green line, to be able to 
generate a command. 
 
6.2.2.6 Commands and customization 
The software platform includes a customization panel. Customization is an 
important factor to accommodate variability among users, particularly different 
tasks to perform. In this panel, the user can choose which type of body action 
(corresponding to a specific sensor) will be performed for control and which third-
party application should receive the command events generated by the user. As 
an example, Figure 32 shows our system controlling an onscreen keyboard for a 
writing task. Threshold can also be manually adjusted, as aforementioned. 
 
6.3 Exploratory study 
6.3.1 Participants 
With the objective of qualitatively evaluating our system, we performed an 
exploratory study including three of the participants in our research. All patients 
were between 50 and 65 years old. The selection criteria were: severe motor 
impairment in UL (few movements that patient could control) and strong 





Figure 32 - Example of the developed platform, controlling an onscreen keyboard to perform a writing 
task in a ©WordPad (from Microsoft) document. In this example, when detecting a control signal from EMG 
generated by the user, the key “Enter” is sent by the platform to the application of onscreen keyboard. This 
command performs a selection using the scanning method. 
 
6.3.2 Procedure 
Experiments were performed in a single session per participant, in their 
usual daily environment (Residence in Table 10). The purpose and procedures of 
the study were explained to patients and caregivers, before informed consent. 
Participants and caregivers were asked to give their opinion on the system, after 
the assessment. Patients were asked to show movements that they could perform; 
sensors were chosen according to the physical characteristics of those 
movements (Table 10). 
 
Table 10. Selected patients included. For each participant, this table describes the place where they live, 
clinical condition, residual movements that were used for this study, speech preservation and the sensors 
tested. 
Participant Residence Clinical Condition 
Residual Movement(s) 
in Upper Limbs Speech Sensors 
P1 Home ALS Right hand (closed)  No speech ACC;FSR 
P2 Elderly  residence ALS  
Slight movements of 
the left hand fingers 
and muscle 





P3 Long term care clinic ALS 
Slight movements of 
right index finger No speech ACC, FSR 
FRS: force resistance sensor; ACC: accelerometer; sEMG: surface electromyography 
  
A computer screen was used to provide visual biofeedback of the input 
biosignal (both input signal and processed control signal) to the patient, in real-
time. For each setup, participants tried to voluntarily activate the input signal by 
visualizing it (and its corresponding control signal) on the computer screen. 
Patients explored the system for approximately 2 minutes, watching the input 
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biosignal and practicing simple cause-effect activities. Then, participants were 
asked to perform two tasks: (Task1) to generate 5 to 10 onsets of the signal; and 
(Task 2) to generate an onset and hold it for 5 seconds (not considered for ACC 
sensors). 
 
    
 
Figure 33 – (left) Accelerometer for detection of slight movements of index finger from the left hand; (right) a 
FSR sensor placed below the thumb finger from the right hand. 
Qualitative outcomes were: sources (input biosignals) with which users 
could fulfill the proposed tasks, types of sensors that best fit to different residual 
movements and main difficulties observed in fulfilling the proposed tasks. 
Quantitative outcomes were: duration and number of onsets performed in each 
task.  
6.3.3 Results 
None of the patients had previous training sessions. We assessed voluntary 
control of movements in the body, with the feedback of patients, caregivers and 
therapists (in the case of P3), as depicted in Figure 33. After selecting the body 
sites and sensors to generate input biosignals, in each participant, we started the 
tests. Results are described in Table 11. Patients were able to fulfill the first task 
with one or more input biosignals. P2 was the only one who could voluntarily 
perform a long activation (Task 2) of the control signal (5025.2 ms) with the FSR 
sensor. P1 and P2 could control more than one input biosignal using ULs. P3 
needed a longer time to deactivate the signal. Duration of activations in Task 1 is a 
measure for the ability to activate and deactivate a command in the control signal, 
equivalent to press and release a key or switch. Input biosignals corresponding to 
Task 1 are depicted in Figure 34, Figure 35 and Figure 36 for each patient tested 
in this study, respectively.  
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Table 11. Characteristics of the selected input biosignals for tasks T1 and T2 
Part.(a) Sensor Body placement Task 1 onsets (b) 
Task 1 
Duration (c) (s) 
Task 2 
Duration (b) (s) 
P1 FSR Right thumb pressure 5 / 5 2.5±1.1  
(0.9 to 2.8) 
No control 
P1 ACC Right thumb movement 5 / 6 1.1±0.1  
(0.9 to 1.2)  
n.a. 
P2 ACC Left index finger 10 / 10 0.4±0.1  
(0.3 to 0.6) 
n.a. 
P2 FSR Left index finger  10 / 10 0.4±1.0  
(200 to 599) 
5.0 
P2 sEMG Left arm 
Biceps 
10 / 10 0.5±0.1  
(0.3 to 0.6) 
No control 
P3 FSR Right index finger 3/4 2.2±2.6 
(0.4 to 5.8) 
No control 
(a) Participant 
(b) Number of performed onsets / Detected activations 
(c) Duration of each signal activation: Mean±Standard Deviation (Range) 
FSR: force sensitive resistor; ACC: accelerometer; sEMG: superficial electromyography 
 
6.4 Discussion 
We developed a new input device for patients with severe functional 
impairments in upper and lower limbs. One of the main positive aspects of our 
proposed system was the flexibility to adapt to each user’s characteristics. Due to 
the option for using different sensors and body sites, participants in this 
exploratory study did not have to change their environment or position to perform 
the proposed tasks. Moreover, we could observe that visual biofeedback is an 
important tool for assessment and training control of residual movements. In our 
tests, this tool was used, both by the patients, to learn to control the biosignal, and 
by the caregivers, to analyze and give feedback to the patients in the learning and 
motivation process before the tests. 
Our input device showed to be a valid instrument to glean new sources of 
input biosignals captured on the body. In spite of the small number of patients and 
difficult physical conditions of our target population, results from experimental tests 



















Functional evaluation of UL dysfunction in ALSFRS-R underestimate 
residual movements that patients can perform when muscle weakness is severe 
(Wicks et al., 2009). However, these residual movements can be important for 
support in communication. In this exploratory study, patients could use residual 
movements in fingers and arm to generate input signals. In particular, 
accelerometer should be further explored as a light sensor that can capture slight 
movements which cannot be used to press keys or switches. Input signals that are 
generated from those slight movements may be used with various purposes: to 
control an ACD with scanning method access, to perform a “select” command in 
eye-tracking devices, to activate a bed alarm or be connected to any other device.  
The more input signals that a patient can generate, the more possibilities 
they have to communicate. Our system allows the assessment of function in 
performing residual movements that can be used for communication. In ALS or 
other neurodegenerative conditions, regular assessment of input signals is 
important to follow disease symptoms and enhance patients’ function in accessing 
to communication tools. For the rapid progression and patients’ dependence on 
caregivers, assessment tools and input devices that are easy to learn and control 
will have better acceptance from patients and caregivers.  
As future work, tests must be performed on a broader range of users, 
exploring new algorithms for automatic detection of voluntary actions. More types 
of sensors to capture new biosignals on the body will also be tested with this input 
device. 
6.5 Conclusions  
We developed a novel input device for ALS-patients with general muscle 
weakness. The developed system allows the use of different sensors to detect 
residual movements that are not considered in clinical functional evaluation of UL 
(ALSFRS-R). We evaluated input biosignals from three different sensors 
(accelerometer, force and electromyography) on different body parts, in this 
exploratory study that included three ALS patients in their daily care context. From 
a qualitative analysis, we could observe that our system was easy to setup and 
learn; it was also flexible to robustly transduce residual movements from multiple 
sources in the body. Biofeedback is an important feature of this system: patients 
could explore residual movements, visualize them in real time on the computer 
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screen and learn how to control them. In particular, concerning neuromuscular 
degenerative conditions, our system is important for assessment of input signals 
that a patient can generate, during progression of disease symptoms. 
6.6 New findings and their importance under research goals 
We developed a new input device for the most severely impaired ALS-
patients. Novelty of this new input device is the possibility of being used as an 
assessment tool to detect sources of input signals that are not considered in 
clinical functional evaluation. We propose biofeedback as a tool for assessing and 
learning new input signals that can be controlled by the patient to access to 
communication tools.  
This work also contributes with design requirements that are necessary for 
the development of new input devices that are to be implemented in the context of 
ALS-patients in late stages, with no previous experience on using assistive 
communication tools.  
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Chapter 7  - Discussion 
7.1 General discussion of the overall work 
This work tested the value of ACD on improving the QoL in ALS, from early 
to late stages. We hypothesized that early support for the use of ACD has a 
positive impact on the QoL of ALS-patients (and their caregivers) and we 
developed a methodology to quantitatively measure functional performance of 
written communication in early stages. We investigated markers of disease 
progression in communication tasks (typing and voice recording activities), 
considering that ACD can be used as tools for this purpose. A framework to 
explore novel monitoring tools based on typing and speech activities, in early 
stages of ALS, and novel functional input biosignals, in late stages, was an 
important contribution of this research. 
7.1.1 On upper limbs functional performance for using assistive devices  
Progression of UL dysfunction varies among ALS patients. It depends not 
only on the onset symptoms, but also on time of progression and the specific 
pattern of disease progression. Functional progression of UL symptoms may be 
evaluated with ALSFRS-R, as described in section 1.2, which assesses function in 
different activities of daily living. In this research, we studied methodologies to 
measure and characterize progression of UL function that is related to the use of 
ACD.  
We found that handwriting performance is correlated to ALSFRS-R-ul, as it 
was expected since the function of handwriting is evaluated in this subscore of 
ALSFRS-R. It is interesting to note that our method to measure handwriting 
performance can be used as a quantitative method to evaluate handwriting, which 
is well correlated to a clinical tool that is broadly used in ALS (ALSFRS-R). 
Concerning the use of the computer to write, typing performance is very 
dependent on patients’ experience in using keyboards for writing. Performance of 
WPM relates to the number of keystrokes per minute, which depends on the 
memorization of the keyboard. For this reason, our results showed high variations 
of typing performance between patients. Still, we can conclude that typing 
performance is a measure of functional ability to use a keyboard and it can be a 
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quantitative measure of experience in use. Typing performance was not correlated 
to ALSFRS-R-ul, suggesting that ALSFRS-R may not be sensible to the function of 
using a keyboard or, more generally, an ACD. Results of this work are in 
agreement with the extension suggested by Wicks et al. (2009) for the ALSFRS-R, 
concerning control of assistive devices, as described in section 2.3.1.2. This 
extension should be used in the assessments for the use of ACD. 
By evaluation of features of keystrokes extracted from the acceleration 
signal in a typing activity, we found that it is possible to monitor UL dysfunction 
that is relevant for the use of ACD. As the disease progresses, the increasing 
delay in performing keystrokes, as well as decreased acceleration of movements, 
are quantitative measures for the increasing difficulties of ALS patients in using a 
keyboard or pressing a switch. Analysis of typing can then be used as a 
quantitative method to mark UL dysfunction in ALS and contribute for the 
anticipation of the need for alternative input devices in support for communication. 
7.1.2 On longitudinal data collection in ALS, involving patients’ interaction 
As ALS progresses, several factors, mainly related to the rapid aggravation 
of symptoms, difficult a long cooperation of the patient and their caregivers in 
longitudinal research studies that involve their active participation. We studied a 
group of ALS patients with bulbar onset. This group of patients represents 25% of 
all patients and has a more rapid functional decline, which raises a difficulty for 
longitudinal studies. Notwithstanding, rapid progression was also an advantage for 
the aims of the research, since it allowed faster observation of progression of 
symptoms and stages in ALS. 
We followed a total of 30 patients with ALS, who were included in data 
collection of the different studies in this thesis. The cooperation of patients and 
caregivers was needed to monitor the use ACD, fill-in the questionnaires and 
perform the tasks related to speech, handwriting and typing recordings. Dropouts 
and variation in the number of assessments between different patients were 
mainly related to death or decreased motivation of some patients or caregivers to 
cooperate due to fast progression. As dysfunction increased and new 
complications (mainly related to feeding problems) demanded decisions on 
complex clinical intervention (sometimes hospital admission), collaboration for the 
evaluation tests was interrupted or depreciated, mainly by the caregivers. As 
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stated in Bedlack et al. (2014) “studies of people with advanced ALS are possible, 
but subject retention and protocol adherence are challenging”.   
7.1.3 On the methodology for data collection  
The methodology developed to monitor disease progression is based on 
spoken and written material collection. Having hypothesized that ACD could be 
used for in-home monitoring, we developed techniques to extract features from 
data that was captured with simple tools: a simple laptop computer or tablet 
device. Despite the fact that most data from patients was collected at clinical 
settings, the methods that we developed can be used in the patients’ home 
environment. Voice was captured with a voice recorder that is embedded in the 
computer; handwriting and typing performance were calculated from the time 
duration of each task’s completion. Concerning data from the accelerometer, our 
procedure was simple and quick to set up. Furthermore, one of the features of the 
study with the accelerometer, the mean time while pressing down the keys of the 
keyboard, can be recorded using software tools (with no need to use the 
accelerometer or other additional equipment). 
In ALS, the complexity and duration of the tests is critical to longitudinal 
studies that are dependent on the motivated involvement of patients. We used 
simple and short sentences, contrary to other clinical tests that require long 
collaboration of patients and controlled settings.  
Simplicity of procedures and equipment used in our research methods 
contribute to asseverate further exploitation of the methodology of this research in 
studies for in-home monitoring with ACD. 
7.1.4 A patient or a user of technologies 
Assistive technologies are framed in the field of Rehabilitation. In this 
perspective, the emphasis on dysfunction, as focused in this research may raise 
controversy. In fact, assistive technologies were defined as services, products or 
strategies to enhance function (described in Section 2.1), which is in accordance 
to the International Classification of Functioning, Disability and Health (WHO, 
2001). In our research work, some methodologies were focused on the evaluation 
of dysfunction. Also, the focus on the subject patient may be controversial to those 
who consider assistive technologies in the framework of modern holistic models 
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for Disability. The specific case of ALS and some other neurodegenerative 
diseases must then be considered.  
In ALS, disease progression has no return. Vital support is needed from 
early stages in most of the bulbar onset patients. Symptoms manifest rapid 
changes in overall functionality, and demand close clinical support. For these 
facts, the user of assistive technologies in the context of ALS is always a patient. 
As so, decisions on support with ACD must not disregard clinical intervention in 
other areas than communication. On the contraire, ALS patients is a target group 
where the close work of the engineers with clinical professionals, patients and 
caregivers is absolutely necessary for the adequate and successful support with 
ACD.  
7.1.5 Benefits of early support in assistive communication 
As tablet devices and Internet tools became popular and accessible in the 
mass market, most patients are starting to use communication tools prior to clinical 
communication support. Many clinicians still consider handwriting as a preferable 
communication tool when patients claim decrease in speech intelligibility with no 
decreased function in ULs; or consider the use of ACD as an ultimate resource, 
when speech and ULs are no longer accessible. This arises particularly for 
patients with low school education or socio-economic levels. Despite the fact that 
there are various software applications that can be used as communication tools 
for ALS patients with severe dysarthria but high function in ULs, clinical 
intervention should intermediate the choice of these tools early, to help the 
patients to potentiate its use in further stages of the disease (Azevedo et al., 
2009). If patients start being supported to use communication tools that can be 
further used in later stages, it is possible to raise motivation and economize 
patient’s efforts to learn and adapt to new devices, as the disease progresses. As 
Miyasaka (2013, pp.165) remarks: “every time an input device is changed, not only 
does the patient have to learn how to use it, but the caregivers also have to learn 
how to install each new device. Therefore, change a communication device can 
become a major hindrance for maintaining continuous communication in ALS 
support”.  
Positive impact in early intervention of clinicians in assisting the use of ACD 
includes: (1) improved quality of life for patients and caregivers, (2) soft adaptation 
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to communication tools, since patients may start to use simple devices for learning 
how to use the software tools and adapt to new input devices as the disease 
progresses, with reduced effort for learning new communication tools (as 
discussed in Chapter 4); (3) decrease in the cost of equipment, since a planned 
strategy for communication reduces changes of devices as the disease 
progresses; and (4) the possibility of monitoring the disease progression 
continuously in daily living (as hypothesized in Chapter 5). 
7.2 Summary of Main Results 
This work focused on the use of assistive communication devices by 
patients with ALS, from early to later stages. We found that: 
1) Early intervention with communication tools has a positive impact on QoL of 
both patients and caregivers. A trend for positive impact was found on 
psychological, well-being and support domains of quality of life (Chapter 4).  
2) ALSFRS-R may not be sensitive to functional skills needed to assessment in 
the use of communication devices:   
a) Typing performance was not correlated to clinical functional assessment of 
UL (ALSFRS-R-ul); patients could perform typing for longer than 
handwriting, as ULs function decreased (Chapter 4).  
b) Main difficulties in using ULs for accessing to ACD are increasing delay for 
pressing and releasing buttons (or keys) and reduced acceleration of 
movements (Chapter 5).  
c) Despite decrease in functional scores of ALSFRS-R, patients with poor 
experience in using computer devices improved performance in typing, as a 
result of having learned how to use communication tools (Chapter 4).  
3) Assistive Communication Devices can be used as tools to monitor progression 
of ALS.  
a) We defined a methodology to collect typing activity and speech with a 
simple and fast procedure that can be replicated out of the clinical setup, 
using ACDs (Chapter 5). 
b) Typing activity and speech recordings of running speech, carried out in 
ACs, can be used as tools to monitor progression of symptoms related to 
communication, on a continuous mode (Chapter 5).  
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4) We developed a new tool for the assessment and control of input signals 
based on various biosignals captured on the body, in particular for patients in 
late stages of ALS, that are severely disabled (Chapter 6). 
7.3 Limitations of the study 
Measuring the effect of the use of ACD on the quality of life of patients and 
caregivers was a main objective of this research. Due to the exploratory nature of 
our study, we analyzed multiple domains of quality of life. Despite the fact that we 
found a trend for a positive impact in some domains, we could not find statistical 
significance in results when considering correction for multi-comparisons. 
Nevertheless, results indicate that psychological, existential well-being and 
support domains should be investigated in further research on the impact of 
communication tools in ALS.  
It is not possible to isolate the effect of a single variable in a disease that 
affects several physical functions in a progressive way. Quality of life may be 
affected by multiple other factors than communication. In the same way, the use of 
ACDs may be conditioned by physical dysfunction but also by multiple personal 
and social factors. Following these statements, the methodology based on 2 to 6 
months intervals for evaluation of the use of ACD may be insufficient to reach 
rigorous results on aspects related to the use of assistive devices.  
Another limitation of this study was that, in spite of the fact that all patients 
were a homogeneous group of ALS patients with bulbar onset, there was a 
considerable variability between patients. Main reasons were: different 
characteristics of progression, different disease stages and motivation, or 
difficulties in following patients due to their absence to scheduled clinical 






Chapter 8  - Perspectives and Future 
Work 
8.1 Impact of early support of ACD on longitudinal research for ALS 
Overall, studies performed in this thesis have exploratory characteristics 
due to multiple comparisons and reduced samples. Nevertheless, we developed 
methodologies and novel techniques that can be replicated in future projects on 
the use of communication tools in ALS. Further studies should include a larger 
sample of patients and controls are needed. 
We studied the effects of early intervention in the use of assistive 
communication. From results of this research we hypothesize that early 
intervention with ACD will reduce the cognitive effort of later support in 
communication. Those patients that gain skills for using communication tools in 
early stages will be more motivated to use those tools during the course of the 
disease. Further investigation is needed to study the impact of early use of ACD 
on patients’ motivation and acceptance of more complex technologies in later 
stages (e.g. the impact on the use of BCIs). 
Concerning the study of the markers of disease progression using UL and 
speech functions, future research is needed to test the proposed methodologies in 
a larger population of patients with ALS, using remote data collection. Continuous 
data from a large group of patients would improve the characterization of UL and 
speech dysfunction towards a better clinical support for the use of ACD.   
Most studies that involve the collaboration of patients are difficult to proceed 
when motor impairment is high. Methodologies that were developed in this 
research for the early use of ACD can be further explored for the development of 
new tools for assessing patients from home, from early to late stages. Evaluation 
instruments that can be accessed and filled-in by patients through communication 
tools can support novel longitudinal research, for example on cognitive screening 
or quality of life evaluation. 
8.2 Other populations that may benefit from the findings in this work 
Our results can be further explored in other progressive neurological 
conditions. While some aspects of the disease symptoms can be specifically 
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characteristic of ALS, methods and technologies used in this research work can be 
interesting in the study of disorders that limit communication but not language and 
consciousness (McCluskey, 2013). Methods that were developed during our 
research for using ACD as a tool to monitor speech and UL progression can be 
further explored for either progressive or potentially reversible disorders. Some 
examples are Parkinson’s disease, Muscular Dystrophy, Multiple Sclerosis or 
some stroke conditions. Moreover, the developed platform for the use of different 
input biosignals, based on biofeedback training, was generally designed for those 
who are severely disabled. We have performed another study with two patients 
with brainstem stroke and one with traumatic brain injury for the assessment of 
input biosignals, which demonstrates application of this novel platform to other 
conditions than Amyotrophic Lateral Sclerosis.   
8.3 Modern paradigms for Assistive Communication Devices  
Research on how people interact with technology is leading a more 
comprehensive approach on the design of technologies that engage patients, their 
caregivers and health professionals. While traditionally, technologies developed 
for Healthcare were exclusively for the use of health professionals (for example, 
tools for diagnostic, monitoring or treatment purposes), presently, technologies 
that are also used by the patients and improve the flow of information and 
communication between all parts (patients, caregivers and the care team) are 
providing novel integrated experiences of Healthcare (Ball & Lillis, 2001; Urmimala 
et al., 2014). 
In addition to the primary objective of ACD of compensating speech or UL 
dysfunction in ALS, we advocate that these devices are also valuable instruments 
to support the aforementioned novel integrated experiences in Healthcare. In fact, 
ACD are technologies to be used by the patients in their daily living environments 
to improve communication and social connections, enhance function in various or 
specific activities of daily living and preserve autonomy. Furthermore, in the frame 
of the neurological progressive diseases, modern ACD can give to ALS patients 
the access to a framework of new services, devices and strategies that is being 
developed with enormous impact in Europe: the Ambient Assisted Living (AAL)3 
                                            
3 AAL. The general objective of this new field of research (created in the context of European demographic 
changes) is to support mass research and development of information and communication technologies that enhance the 
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(Röcker & Ziefle, 2011). In line with the general objectives of AAL, assistive 
communication devices can be further explored as personal health systems 
(INTEL, 2008) playing a major role in connecting the patients to the health and 














                                                                                                                                    
quality of life, extend the autonomy and social participation of the elderly population and thus, reduce the costs of health and 
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Appendix A - Speech and phonation 
modelling 
This appendix includes a description of the methodology used in estimating 
formant positions, spans, area and centralization, to derive the indices for jaw and 
tongue neuromotor affection, as extensively described in Gómez-Vilda et al. 
(2015). 
Speech recordings were used to estimate a prototype of the vowel triangle 
(as in Figure 26) in the domain of the first two formants F2 vs. F1 corresponding to 
pairs {F1(n), F2(n)}, where n is the discrete time index. Formant distributions used 
to estimate the distribution quantiles were: 
 a) 
where γi(ν) is the probability density function of formant i in frequency ν, and 
θ is the specific quantile threshold (for instance θ=0.03 would correspond to a 3% 
quantile). In the present study the following definitions apply: θ1=0.03, θ2=0.5 and 
θ3=0.97.  
A.1 Ideal vowel triangle 
An ideal vowel triangle enclosing most of the pair estimates {F1(n), F2(n)} 
was defined (as illustrated in Figure 26) by the vertices given by 
 i) 
where Vtl, Vbl and Vcr are correspondingly the top left, bottom left and center 
right vertices, corresponding approximately to the positions tending to extreme 
vowels /i/, /u/ and /a/ on the standard vowel triangle.  
Triangle geometrical centroid Cg (intersection of angle bisectors), formant 

































where the geometrical centroid coordinates f1g and f2g can be estimated as: 
 ii) 
A.2 Formant spans (∆F1 and ∆F2) 
The formant spans ΔF1 and ΔF2 are defined as the range swept by both 
formants referred to the vertices in the ideal vowel triangle. Their normalized 
versions are evaluated in reference to the geometric centroid { , } of 




A.3 Modulus of the normalized formant span (MNFS) 
The formant span may be seen as a vector with the modulus and argument: 
  iv) 
 




































































































































































Appendix B – Questionnaires of Quality 
of Life and Communication  
B.1 ALSFRS-R 
 
1. ARTICULAÇÃO VERBAL 
Discurso normal         ! 
Perturbações detectáveis no discurso      ! 
Inteligível com repetição        ! 
Discurso combinado com comunicação não verbal     ! 
Perda do discurso útil                                             ! 
2. SALIVAÇÃO 
Normal          ! 
Ligeira, mas com excesso de saliva na boca, talvez se babe durante a noite  ! 
Moderado excesso de saliva, um mínimo de baba     ! 
Marcado excesso de saliva: com alguma baba     ! 
Marcado excesso de baba: requer uso constante de lenço    ! 
3. DEGLUTIÇÃO 
Hábitos alimentares normais       ! 
Problemas prematuros ao comer, com ocasional sufocamento   ! 
Alterações na consistência da comida      ! 
Necessita de sonda para alimentação suplementar     ! 
Não se alimenta pela boca (alimentado exclusivamente por via  
parentérica ou entérica)         ! 
4. ESCRITA 
Normal          ! 
Lenta e irregular, todas as palavras são legíveis     ! 
Nem todas as palavras são legíveis       ! 
Capaz de agarrar a caneta, mas incapaz de escrever    ! 
Incapaz de segurar a caneta       ! 
5.a. CORTAR A COMIDA E MANEJAR OBJECTOS (doentes sem gastrostomia) 
Normal          ! 
Algo lento e desajeitado mas não necessita de ajuda    ! 
Pode cortar a maior parte da comida, embora lento e  
desajeitado, necessita de alguma ajuda      ! 
A comida tem que ser cortada por alguém, mas ainda se  
consegue alimentar lentamente       ! 




5.b. CORTAR A COMIDA E MANEJAR OBJECTOS (doentes com gastrostomia) 
Normal          ! 
Desajeitado, mas capaz de desempenhar todas as actividades independentemente ! 
Precisa de alguma ajuda para apertar e desapertar o botão da gastrostomia  ! 
Dá ajuda mínima à pessoa que cuida dele/a      ! 
Completamente dependente       ! 
6. VESTIR E HIGIENE PESSOAL 
Normal          ! 
Independente apesar da tarefa requerer esforço e ter eficácia diminuída  !   
Ajuda intermitente ou substituição de métodos     ! 
Necessita de auxilio para cuidado pessoal      ! 
Total dependência         ! 
7. VOLTAR NA CAMA E AJUSTAR A ROUPA DA CAMA 
Normal          ! 
Algo lento e desajeitado mas não necessita de ajuda    ! 
Pode virar-se sozinho e ajustar os lençóis mas com muita dificuldade  ! 
Pode iniciar mas não voltar-se ou ajustar os lençóis sozinho    ! 
Incapaz          ! 
8. ANDAR 
Normal          ! 
Prematuras dificuldades ambulatórias      ! 
Caminha com ajuda         ! 
Apenas movimento funcional não ambulatório     ! 
Sem movimentos úteis dos membros inferiores     ! 
9. SUBIR ESCADAS 
Normal          ! 
Lento          ! 
Moderada instabilidade e fadiga       ! 
Necessita assistência        ! 
Impossível          ! 
10. RESPIRAR  
Normal          ! 
Falta de ar para mínimo esforço (ex. andar, falar)     ! 
Falta de ar em repouso         ! 
Assistência ventilatória intermitente (ex. nocturna)      ! 
Dependente do ventilador         ! 
 












































B.4 Communication Effectiveness Index (adapted and translated from 
Beukelman et al. (2000) 
 
 Com que eficácia comunica quando... 
 
1. conversa com pessoas familiares num ambiente calmo? 
0 ! 1 ! 2 ! 3 ! 4 ! 5 ! 
Não comunico    Faço-me entender muito bem  
2. conversa com estranhos num ambiente calmo? 
0 ! 1 ! 2 ! 3 ! 4 ! 5 ! 
Não comunico    Faço-me entender muito bem  
3. conversa ao telefone? 
0 ! 1 ! 2 ! 3 ! 4 ! 5 ! 
Não comunico    Faço-me entender muito bem  
4. conversa em ambiente ruidoso (ex: evento social, restaurante, centro comercial)? 
0 ! 1 ! 2 ! 3 ! 4 ! 5 ! 
Não comunico    Faço-me entender muito bem  
5. conversa com alguém a uma certa distância (entre divisões da casa)? 
0 ! 1 ! 2 ! 3 ! 4 ! 5 ! 
Não comunico    Faço-me entender muito bem  
6. fala para um grupo (ex: jantar familiar)? 
0 ! 1 ! 2 ! 3 ! 4 ! 5 ! 
Não comunico    Faço-me entender muito bem  
7. conversa com o seu médico? 
0 ! 1 ! 2 ! 3 ! 4 ! 5 ! 
Não comunico    Faço-me entender muito bem  
8. conversa com o seu cuidador? 
0 ! 1 ! 2 ! 3 ! 4 ! 5 ! 
Não comunico    Faço-me entender muito bem  
9. quer transmitir uma situação importante e urgente (p.ex., pedir ajuda)? 
0 ! 1 ! 2 ! 3 ! 4 ! 5 ! 
Não comunico    Faço-me entender muito bem  
10. transmite necessidades e opiniões acerca de decisões importantes para a sua vida? 
0 ! 1 ! 2 ! 3 ! 4 ! 5 ! 




Appendix C – Transcription of 
communication from some patients and 
caregivers (in Portuguese) 
Patient A 




“a doença roubou-me quase tudo, o corpo, os amigos que afinal não existiam, 
toda uma vida... não me roubou a dignidade, os afectos, a relação com os outros 
é bom receber algo mais por mim. 
(…) que posso comunicar e estar ligada ao mundo que posso estar agora a falar 
consigo é tão bom dizer o que penso e exprimir os meus sentimentos sem ser os 
outros a falar por mim.(…)” 
“no dia oito de abril vou à gastro mostrar a peg porque tem comida agarrada ao 





[Saved on a text file (in the ACD) to present in the clinical appointment] 
 
 “BOA TARDE PROFESSORA ANABELA.  ESTOU A AGUARDAR NOVA CONSULTA ESTANDO 
NUMA SITUAÇÃo RAZOAVEL DE SAUDE COM OS LIMITES HABITUAIS ,MAS TENHO 
ULTIMAMENTE ALGUMAS DORES NO PESCOÇO TENDO  ALGUMAS DIFICULDADES 
QUANDO  ME MOVIMENTO PARA O LADO DIREITO. NA MOBILIZAÇÃO O LADO DIREITO 
ESTÁ MAIS FRACO, ESTANDO A FALA TAMBEM MAIS FRACA.APESAR DESTAS 
FRAQUEZAS MANTENHO-ME TRANQUILO NÃO SÓ PELO CONHECIMENTO DO 
160 
CONSUMISMO DA DOENÇA MAS TAMBEM PELA EQUIPA MEDICA QUE ME DÁ 
ASSISTENCIA  (PROFESSOR MAMEDE  E  PROFESSORA ANABELA), PELO QUE JA FICAVA 
FELIZ SE O CONSUMISMO FICASSE COMO ESTOU E ASSIM VIVER AINDA MAIS 
TRANQUILO. PROFESSORA ANABELA ,FUI RECENTEMENTE SURPREENDIDO COM UMA 
CONSTIPAÇÃO COM MUITA  ESPETURAÇÃO  A JUNTAR-SE Á QUE JA EXISTIA E TOSSE 
QUE ME ATACA MUITO Á NOITE O QUE ME LEVOU A NÃO CONSEGUIR COLOCAR A 
MASCARA ,FELIZMENTE VOU ESTANDO MELHOR PELO QUE ESTOU CONVENCIDO QUE 
DENTRO DE DIAS JÁ A  VOU CONSEGUIR COLOCAR,A QUAL,PARA ALEM DOS 
PROBLEMAS QUE NÃO TENHO CONSEGUIDO ULTRAPASSAR,ME DÁ QUANDO POSSIVEL 
ALGUMA TRANQUILIDADE DURANTE O SONO.ESSES PROBLEMAS QUE A PROFESSORA 
ANABELA JA CONHECE(FUGAS) QUE ME DÃO GRANDE TURBELENCIA E 
DESGASTE,COMPLICAM A NOITE.CONSULTEI O MEU DENTISTA O QUAL ME DISSE QUE 
NÃO É A PLACA DENTARIA QUANDO A TENHO COLOCADA ME PROVOCA ESSAS FUGAS E 
QUE ME ACONSELHA A NÃO DORMIR COM ELA COLOCADA. SUBLINHOU AINDA QUE 
ESSAS FUGAS PODEM TER ORIGEM DA FALTA DA PLACA MAS TAMBEM ESSA FALTA E A 
MAGREZA DA CARA SE JUNTAM NA ORIGEM DESSAS FUGAS,SENDO ATÉ 
POSSIVELMENTE A  MAGREZA A UNICA CAUSA DESSAS FUGAS.JÁ SEI QUE A MINHA 
ESPOSA CONTATOU A PROFESSORA ANABELA E QUE VOU TER CONSULTA NA PROXIMA 
QUARTA- FEIRA.”      
 
Patient C 
 [Typing on a keyboard using upper limbs. Using a speech synthesizer for the first 
time. Communication with her husband and with me.]  
    
“tenho de ir fazer compras. Ouviste? Agora estás tramado comigo. 
É tanta coisa é normal esquecer.. mas quem é que paga os computadores?  
tudo vale a pena se a alma nao e pequena” 
 
 
[Three months later, this patient is using a head switch for writing on a virtual 
keyboard, due to severe dysfunction of UL. She wrote:] 
“vamos ao decatlokn e ao oikea conpras roupa e almofadas que esta calor  a 
maria qpodia fazer sopa de ervilhas com ovo a maria pode vir as 10 h mané 
podias ir com o joão amanhã as compras a maria faz lista do que falta nao temos" 
 
[Her son after her mothers’ death:] 






 [A patient was telling me what her son told her, after she started using the ACD 
with speech synthesizer:] 
 
“don’t exaggerate[referring to the use of the ACD]. Keep talking” 





[email that I received from a patient, about her computer:] 
“quarta-feira, 8 de Abril de 2015 
Se tudo na vida tem uma razão de ser, eu continuo a procurar explicação para um 
sem número de provações a que fico sujeita ... ! Estive nove dias sem me poder 
comunicar ..... já é penitencia bastante estar prisioneira em meu próprio corpo e 
estar privada de falar sem o único meio de comunicar que é o computador, é 
sentir -me enterrada viva só com os olhos de fora ! 
Como são importantes as palavras faladas para a própria sanidade mental ... ! 
porque quando se tem de ouvir sem a capacidade de fugir, argumentar e 
responder, fica uma tarefa muito ardua para um simples mortal !!! 





















Appendix D - Published papers facsimile 
 
 
